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ABSTRACT
Standardisation of a homologous antibody-dependent eel 1 -
mediated cytotoxicity (ADCC) assay was achieved by
evaluation in vitro of non-adherent peripheral blood
lymphocytes (PBL) from 120 healthy individuals for their
intrinsic activities in lysing group 0 R ^ R ^ red cells
sensitized with a particular anti-D which had proved to
be highly active in ADCC despite having a low concen¬
tration of antibody as measured by conventional haemag-
glutination methods. The use of different ratios of
51
lymphocytes (effector cells) to Cr-labelled OR^R^
red cells (target cells) allowed the construction of
51
dose response curves, where the Cr release (X specific
lysis) was plotted against effector:target cell (E/T)
ratios. In these curves % specific lysis started to
plateau at an E/T ratio of 10:1. The results suggested
that in this system the intrinsic lymphocyte ADCC activ¬
ity in healthy (non-immunized) individuals was indepen¬
dent of age, sex and blood group of the donor. It was
also found to be constant when tested sequentially in
individuals, although differences between individuals
were found to exist.
The standardised ADCC assay was used to study the lytic
potential of anti-D sera from different sources. Anti-D
ADCC activity did not correlate with any of the conven¬
tional haemaggluti nation assays used. However, unexpec¬
ted differences were found between the ADCC activity of
anti-D produced in deliberately immunized males and that
\J
induced by pregnancy. Although the males produced high
levels expressed in iu/ml, ADCC activity induced was
much less than from females at equivalent concentrat¬
ions. Ig G subclass distribution between the different
sera could not account for these differences. However,
there was a tendency for I g G ^ tit res to be higher where
ADCC activity was seen, and in sera from males, I g G ^
titres were > I g G ^ and ADCC activity was very low.
Certain anti-D sera, selected on the basis of agglutin¬
ation characteristics in vitro, failed to induce lysis
of Rh(D) positive cells by ADCC and it appears that this
anti-D blocked the effect of other anti-D sera (normally
lytic in ADCC) in an antigen specific manner. Studies
of a non-1ytic anti-D showed that the blocking effect
was associated with I g G anti-D. Antigen binding and Fc
receptor binding studies indicated that the non-lytic
anti-D was bound to Rh(D) positive red cells, but failed
to mediate ADCC.
The ADCC assay was used successfully to predict the
severity of haemolytic disease of the newborn (HDN) due
to anti-D. An ADCC assay can in some cases indicate the
outcome of pregnancy affected by HDN more accurately
than can conventional methods.
In a study of changes in intrinsic lymphocyte ADCC acti¬
vity in males participating in the Rh-immunization pro¬
gramme, responders (ie those who produced anti-D) showed
marked depression of ADCC activity after secondary immu-
vi
nization, and this was not seen amongst non-responders.
This was also seen in patients undergoing plasma ex¬
change therapy to reduce maternal concentration of anti-
D, when fresh frozen plasma was used as a replacement
fluid without regard to the Rh groups of the donors.
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1.1 Mechanisms of human red cell destruction
Immune red cell destruction without the presence of
antibody, on an exclusively cell mediated basis, has not
been demonstrated. It has been obvious for most of this
century that two distinct types of red cell destruction
seem to exist. Fairley (1940) used the term "intravas¬
cular" to describe the type of haemolysis associated
with the destruction of red cells in the blood, and the
term " e x t r a v a s c u1 a r" for the breakdown of red cells
within the reticuloendothelial system (RES).
Of particular interest are the haemolytic conditions
mediated by antibodies since these are often encountered
in blood transfusion practice. The mechanisms of red
cell lysis are basically the same whether mediated by
transfusion alloantibodies (or host antibodies to trans¬
fused red cells) as in a haemolytic transfusion
reaction, by transplacental transfer of al1oantibodies
as in haemolytic disease of the newborn (HON), or
mediated by autoantibodies (Table 1).
1.1.1 Immunoglobulin class of red cell antibody
The immunoglobulin class of most red cell anti¬
bodies is I g G or I g M , although I g A forms also
exist. The term immunoglobulin is used to
describe protein molecules that have the ability
to complex specifically with antigen.
Immunological differences between these classes
are associated with the constant (C^) region of




1) RBC + antibody (IgM); C1-C9 complement activation;
intravascular lysis
2) RBC + antibody (IgG or IgM); complement activation to
C3; removal by reticulo-endothelia1 system (mainly
1iver)
3) RBC + antibody (IgG); directly removed by reticulo
endothelial system (mainly spleen)
4) RBC + antibody (IgG); antibody dependent cell mediated
lysis
3
designated gamma (IgG), Mu (Ig M) and alpha (I g A)
(Table 2). Light chains occur as two immuno¬
logically distinct types designated kappa and
lambda. The H chain classes share kappa and
lambda chains. Approximately 70% of light chains
are kappa and 30% lambda. Each antibody molecule
possesses two light chains of the same type ( i e
two kappa or two lambda).
1.1.2 IgG Sub-classes
IgG is divided into sub-classes (I g G. , ~ > 3 and 4)
which differ in their primary structure (Grey and
Kunkel, 1964; Terry and Fahey, 1964). In all IgG
molecules there are inter-heavy chain disulphide
bonds in the hinge region but the number varies
in the different sub-classes. There are two such
bonds in Ig G ^ and I g G ^ , four in Ig G ^ (Nisonoff et
a 1 , 1975) and eleven in I g G ^ (Michael son (1977).
The properties of IgG sub-classes which are
important in the area of immunohaematology are
presented in Table 3.
1.1.3 Role of antibody in destruction of human red
cells
There is much evidence that binding of red cell
antibodies to their antigenic determinants on the
cell membrane does not cause direct damage to red
cells (Mollison, 1972). When complement is
present on the cell, either alone or together
with IgG, the in vivo interactions differ from
4










































Binding site — mast cells
— macrophages
— polymorphonuclear leucocytes
Activating site for K-cells — Triggering site (A)








Biological properties and activities of irmunoglobulin in serum








Heavy chains V M a
Light chains K orA K orA K orA




J chain No Yes Yes
Sedimentation coefficient (S) 7 19 1—' O l—' -P*
Electrophoretic mobility y F-/3 /3
Concentration (mg/ml) - Adult 7-17 7-21 7-35
Concentration (mg/ml) - Navbom > than adult 0.3-3 -
Catabolic rate T 1/2 (d) 23 5 6
% of total which is intravascular* 44 80 40
Synthesis (mg/Kg/day) 20-40 3-55 3-17
Complement fixation Yes Yes No
Binding to Monocytes/macrophages Yes No No
Number of sub-classes 4 1 2
Blood group antibody activity
described Yes Yes Yes
Placental transfer Yes No No
Usual serological activity behaviour
as red cell antibody
Incomplete
antibody Aggl utinin Agglutinin
Serological activity after heating
to 56 C for 3h Unaffected Reduced Unaffected









* Percentage of intravascular poool destroyed daily
Adapted from:
Mol1ison (Blood Transfusion in Clinical Medicine 7th Edition, 1983)
Petz and Garratty (Acquired Immune Haemolytic Anemias, First Published, 1980)
Petz and Wisher (Clinical Practice of Blood Transfusion, First Published, 1981)
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Table 3
Biological properties and activities of human IgG sub-classes
Characteristics IgG1 igG2 IgG3 igG4
Serum (mg/ml) 5-12 2.6 0.5-1 0.2-1
Half-life in days 22 22 5-16 22
Fractional turnover (%) 7 7 17 7
Synthesis (mg/Kg/day) 25 3.4
Placental transfer + + + +
Complement fixation ++ + +++ -




Binding to neutrophils + + + +




Binding to platelets + + + +
Staphylococcal A + + - +
Allotypic (genetic) markers 4 1 12 0
Symbols used: negative; -, weakly positive; +, positive; ++, +++
strongly positive; blank space, not tested.
Adapted from:
Speigelberg (Advances in Immunology 1974, vol 19).
Schanfield (AABB, American Association of Blood Banks, Nov 1977).
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those observed when only IgG is present. Extra-
vascular red cell removal is enhanced consider¬
ably when complement is present on red cells in
addition to IgG. Mollison (1979) showed that red
cells sensitized with 7 to 9 /ig/ml of a comple¬
ment-binding IgG alio anti-Fya were cleared from
the circulation with a half time of 2 to 4 min
(indicating almost complete clearance of the
cells at a single passage through the liver),
whereas red cells sensitized with a similar
amount of non complement-binding I g G antibody
were cleared with a half time of the order of 50
min, indicating negligible clearance by the liver
and only partial clearance at each passage
through the spleen. Schreiber and Frank (1972
a-b) injected normal guinea pigs and guinea pigs
deficient in complement with I g G and
IgM-sensitized guinea pig red cells in different
experiments. The cells survived longer in
animals lacking either C3 or C4 and terminal
complement components, which suggests that
complement played a significant role in determin¬
ing the rate of destruction.
It has been known for some time that I g M anti¬
bodies are somewhat better at activating comp¬
lement than I g G forms, only one molecule of I g M
on a cell membrane being necessary to activate
the complement system (Borsos and Rapp, 1965;
Humphrey and Dourmashkin, 1965). In contrast, it
8
is thought that I g G needs to form a "doublet";
that is, two I g G molecules have to combine with
antigens on the cell membrane as close together
as 25-40 nm before they are able to activate
(Humphrey and Durmashkin, 1965). I g G ^ and I g G ^
molecules are good at initiating complement
activation; I g G 2 molecules have limited ability
in this respect and IgG^ molecules may be unable
11
to activate complement at all (Mu11er-Eberhard,
1969 ) .
It has been shown that most IgG anti-Rh anti¬
bodies are I g G and I g G ^ (Natvig and Kunkel,
1967; Frame e t a 1 , 1970; Abramson and Schur,
1972) yet they very seldom cause complement to be
bound. Mollison (1972) has suggested that this
may be due to the location of Rh antigen sites on
the red cell membrane. It has been suggested
that Rh antigens are mobile within the membrane
and may cluster during antigen-antibody reactions
(Victoria et a 1 , 1976). It is possible that the
ability of antigens to cluster may be an
important factor in immune red cell destruction
as it may influence the ability of antibodies to
activate complement (eg there is a greater
likelihood of IgG forming "doublets") and it may
alter the presentation of membrane-bound Ig G to
the macrophage (Garratty, 1982).
9
Those antibodies which fix complement react at
37°C and cause rapid intravascular lysis of red
cells (Table 1). The red cell membrane is
damaged as a result of activation of the
complement cascade CI to C9 with holes being
produced by enzyme action followed by osmotic
lysis as a result of ions, fluxes and water
II
entering the cell (Mu11er-Eberhard, 1969).
Although it was previously believed that C3b was
primarily involved in bringing about attachment
to macrophages whilst ingestion depended on I g G
(Mantovani et a 1 , 1972), it is now known that
this conclusion applies only to inactivated
macrophages. When macrophages are activated by a
lymphokine, C3b receptors are able to migrate
within the plane of the plasma membrane of the
cell and the cells show C 3 b receptor-dependent
phagocytosis (Griffin and Mullinax, 1981). This
interaction was described as immune adherence and
the receptor to which complement attaches is
known as an IA receptor (Nelson, 1956). It is
now known that the immune adherence receptor
consists of three separate receptors CR1 (for
C3b), CR2 (for C3d) and CR3 (for C 3 bi ) (Ross,
1980). When C 3 b is present on red cells in
addition to IgG, interaction with macrophages is
enhanced; the amount of IgG antibody required for
10
immune adherence in the absence of complement is
quite considerable (approximately 100 times more
- Ehlenberger and Nussenzweig, 1977).
It has been postulated that this mechanism
results in the in vivo blood picture of
spherocytosis, red cell fragmentation and
intravascular haemoglobin seen in immune
51
haemolytic anaemia. By the use of Cr-labelled
red cells it has been shown that C3-coated cells
are removed more efficiently by the liver than by
the spleen (Cookesley et al , 1 9 7 3 ) as the liver
has a larger blood supply. However, red cells
sensitized by Ig G only are destroyed predom¬
inantly in the spleen and it has been shown that
the spleen is about 100 times more efficient than
the liver at removing Rh ( I g G ) sensitized red
eel 1s (Mol1ison, 1 972 ) .
IgG-coated red cells will adhere to human
monocytes leading to rosette formation (Lo Buglio
et a 1 , 1967; Cline and Lehrer, 1968; Huber et a 1 ,
1968). The attachment of IgG-coated cells to
monocytes depends on a site on the Fc fragment;
only IgG^ and IgG^ molecules bring about attach¬
ment (Huber and Fundenberg, 1968, Henderson
1976), the degree of which tends to be greater
with Ig G ^ than with Ig G ^ (Abramson and Schur,
1 97 2 ; Schanfield et a 1 , 1980 ). Further, I g G ^ has
greater affinity than IgG^ for the Fc receptor on
11
monocytes (Engelfriet et a 1 , 1981). Adherence to
monocytes can be demonstrated with Rh (D)
positive red cells coated with anti-D or with
CrCl^-treated red cells coated with Ig G (Lo
B u g1io et a 1 , 1967; Huber and Fudenberg, 1968).
When examined under the electron microscope, red
cells which have been bound to monocytes are seen
to be adhering very closely with coarse
interdigitation between the cells; red cells
which break away have increased osmotic fragility
(Lo Bug1io et a 1 , 1967; Abramson et a 1 , 1 9 7 0a).
Lo Bug1io et a 1 (1967) showed that the reactions
between the Fc receptor on human monocytes, and
macrophages with IgG-sensitized red cells, could
be specifically inhibited with IgG or its Fc
fragment in solution. It was suggested that the
entrapment of antibody-coated red cells in vivo
is enhanced by plasma skimming; the fact that the
spleen is notable for both erythroconcentration
and efficient trapping of IgG-coated red cells
supported this interpretation. Huber et a 1
(1968) have confirmed the inhibitory effect of
even small amounts of normal plasma or serum.
However, Scornic k et a 1 (1975) showed that
IgG-sensitized red cells are rapidly cleared from
the circulation of patients with myelomas in
spite of serum I g G concentrations several times
higher than normal. They concluded that current
explanations derived from in vitro experiments
12
are insufficient to explain the I gG-dependent
clearance of red cells in the presence of free
I g G. Most al1oantibodies (eg Rh, Kell, Duffy)
other than anti-A and anti-B destroy red cells
extravascu1 ar1y. Most of the red cell destruct¬
ion associated with autoimmune haemolytic anaemia
(AIHA) is extravascular. In addition, almost all
drug-induced haemolytic anaemias (e_g those caused
by methyldopa or penicillin) are associated with
extravascular red cell destruction.
It has been demonstrated that red cells sensi¬
tized in vitro with increasing amounts of
anti-Rh(D) antibody have rates of in vivo
destruction which correlate directly with the
degree of antibody sensitization (Mollison,
1979). There is a general correlation between
the amount of antibody taken up on red cells with
the amount of red cell destruction, but there are
extreme examples of non-corre1 ation at each end
of the scale (Garratty, 1982). Cases of AIHA
illustrate the dramatic lack of correlation which
can be seen between in vitro tests and in vivo
red cell destruction. Although some workers
(Rosse, 1971; Petz and Garratty, 1980) have found
that auto-antibodies (like the alloantibodies
described above) show a general correlation
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between the amount of antibody on red ceils (ie
the strength of the direct antiglobulin test,
DAGT) with in vivo red cell destruction others
(Constatoulakis et a 1 , 1963) have found no
correlation. Gilliland et a 1 (1970, 1971) have
explained this as sometimes occurring because of
the small numbers of Ig G molecules (eg 50-200)
present per red cell, and that these molecules
are too few to be detected by the routine direct
antiglobulin test (DAGT): this was confirmed by
Petz and Garratty (1980). Hughes-Jones et al
(1964) and Dupuy et a 1 (1964) have shown that
approximately 200-500 molecules of I g G per red
cell have to be present before a positive DAGT
can be obtained.
Recent in vitro evidence has suggested that
monocytes (Holm, 1972) and lymphocytes (Urbaniak,
1976) may destroy sensitized red cells by
extrace 11u1 ar cytotoxicity in addition to phago¬
cytosis. It is possible that this is a more
important mechanism in vivo than immune
adherence, especially where antibody-coating of
red cells is minimal. It may also be an
alternative explanation for non-complement-
mediated haemoglobinaemia and haemoglobinuria
associated with extravascular lysis. This type
of lysis has been described as antibody-dependent
ce11-mediated cytotoxicity (ADCC) and is a
mechanism which has been shown to result in
14
damage to many types of cells including
allogeneic and xenogeneic red cells, tumour cells
and lymphocytes. It is described in detail in
the following section.
15
1. 2 Antibody-dependent cell-mediated cytotoxicity (ADCC)
The role of lymphocytes in immune red cell destruction
is controversial. Lymphocytes are known to have
receptors for IgG (Fc) and complement (C3b, C3d and C4).
They have been described as being capable of destroying
sensitized nucleated cells (Perlmann and Holm, 1969).
Before the cell is damaged, contact between the
lymphocyte and the target cell has to occur and
complement may or may not be involved. In vitro cell-
mediated lysis requires several hours to occur, even
under optimal conditions. Cell-mediated cytotoxicity is
antibody-dependent where the target cells have to be
sensitized with antibody. The effector cells for this
reaction have been described as possibly being "null"
lymphocytes (ie lacking sheep cell receptors and surface
Ig, but having IgG Fc and complement receptors). They
are either a sub-set of B lymphocytes (Brier et a 1 ,
1975) - the so called "Killer" lymphocytes (K-cells)
which are non-phagocytic and non-adherent lymphocytic
cells (Perlmann and Holm, 1969) - or they represent a
heterogenous family of effector cells (both B and T
cells). Still another group of workers (Shore et a 1 ,
1977) believe that the effector cells are neither B nor
T cells. However, all agree that the cells possess an
Fc receptor (Reviewed by Sanderson, 1981).
1.2.1 The natu re of effector and target cells
influence on ADCC
Great interest has been shown in the true
identity of the cells with lymphocyte morphology
16
which mediate ADCC, as originally described by
Perlmann et a 1 ( 1972 ) and MacLennan ( 197 2 ). A
great deal of earlier confusion in the literature
was due to failure to appreciate the importance
of target cells and their antibodies, and that
there might be inter-species differences. An
important observation was that the type of target
and the source of antibody are important in
determining the nature of the effector
ce1 1 -mediating lysis. In general, it appears
that highly purified lymphoid cells are much more
effective in promoting the lysis of nucleated
target cells such as allogeneic lymphocytes and
tumour cell lines, whereas monocytes are more
effective in lysing red cell targets. It is
interesting to note that chicken red cells are
nucleated and appear to be equally susceptible to
lysis by monocytes and lymphoid cells
(Kovithavongs et a 1 , 1975; Zeijlemaker et a 1 ,
1975). Differences in ADCC activity are seen
when target cells, antibodies and effector cells
from different species are tested in various
combinations (Zighelboim and Gale, 1974).
Urbaniak (1979a) emphasised the importance of
using a homologous system when testing human ADCC
activity in patients.
It has been shown that human cells other than
purified lymphoid cells are active in ADCC, eg
polymorphonuclear neutrophils (PMN) which require
17
greater amounts of antibody (Gale and Zigelboim,
1974, 1975; Oleske et a 1 , 1977; Clark and
Klebanoff, 1977; Levy et a 1 , 1979; Fuson et a 1 ,
1981; Conkling et a 1 , 1982). This may be because
PMN-Fc receptors have lower avidity for Ig G
antibody. Monocytes have also been reported to
lyse antibody-sensitized erythrocytes (Holm,
K
1972; Holm and Hammarstrom, 1973; Papamichael and
Temple, 1975) but to be relatively inactive
against nucleated target cells (MacDonald et a 1 ,
1 977 ; Trinchieri et al , 1975 ). Others have indi¬
cated that monocytes may lyse nucleated cells as
well (Kohl et a 1 , 1977; Horwitz et a 1 ; 1979; Levy
e t a 1 , 1979). Eosinophils have also been
reported to lyse antibody-sensitized red blood
cells (Hanepps and Bankhurst, 1978; Parillo and
Fauci, 1978; Lopez and Sanderson, 1982).
Although chicken red cells were lysed by human
lymphocytes, Holm (1972) reported that human red
cells were not directly lysed in the presence of
anti-A or anti-Rh when the preparation was more
than 99% pure lymphocytes. Hinz and Chickosky
(1972), using a lymphocyte preparation containing
less than 1% neutrophils and virtually no
monocytes, were able to demonstrate cytotoxic
reactions between lymphocytes and group A and
Rh-positive red cells in the presence of anti-A
and anti-Rh respectively. In the anti-A
experiments, lymphocytes from group 0, A or AB
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donors were equally active but in the Rh experi¬
ments only lymphocytes from an Rh hyper-immune
donor would cause lysis of the red cells. Normal
lymphocytes from both Rh-positive and Rh-negative
donors were completely without effect, even in
the presence of a powerful anti-Rh. In contrast,
Urban i a k (1976) was able to show that normal or
autologous lymphoid cells would lyse Rh sensi¬
tized red cells and that killing occurred at very
low antibody concentrations. Recently, other
workers have also reported ADCC against human red
cells mediated by anti-A (Northoff et a 1 , 1978;
Moore and Kimber, 1980) and anti-Rh (Handwerger
et a 1 , 1978 ; Milgrom and Shore, 1978 ; Northoff et
a 1 1978; Moore and Kimber, 1980; Kimber and
Moore, 1981).
Previous systems using anti-A/group A or anti-B/
ii
group B target red cells (Holm and Hammarstrom,
1973 ; Poplack et a 1 , 1 976 ) have demonstrated that
effector red cells include both monocytes (Holm
e t a 1 , 1974) and a non-monocytic lymphoid K-cell
(Urbaniak, 1976; Milgrom and Shore, 1978;
Kurlander et a 1 , 1978). Others have not been
able to demonstrate such activity in vitro (Holm
ii
and Hammerstrom, 1973; MacDonald e t a 1 , 1 9 7 5 ,
Engelfriet et a 1 , 1981). Although the lysis of
such targets by the ADCC mechanism is well
documented, evidence obtained in heterologous
systems using either mononuclear target cells
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(MacLennan, 1972; Ziegler et a 1 , 1977) or chicken
red cells (Perlmann et a 1 , 1972, Wisloff et a 1 ,
1974) and in homologous systems using human red
cell D/anti-D (Urbaniak, 1976) indicates that
intimate cell-to-cell contact is required and
that this is mediated via the Fc portion of
target bound antibody ( I g G class) and an Fc
receptor on the effector cell. Holm and
il
Hammarstrom (1973) reported that monocytes were
much more active than lymphocytes in a D/anti-D
ADCC assay, and found that trypsinisation of red
cells enhanced lysis.
Urbaniak (1976, 1979a, b) has achieved consider¬
able enhancement by papainisation of human red
cells in a K-cell assay and this has been
confirmed by other workers (Shaw e t a 1 , 1 9 7 8 ;
Milgrom and Shore, 1978; Kurlander et a 1 , 1 9 7 9 ) .
The nature of the enhancing effect is unknown but
it is probably a combination of enhanced antibody
uptake by the cells (Masouredis, 1962;
Hughes-Jones et al, 1964) and increased exposure
of Rh antigens in the red cell membrane by
removal of surface glycoproteins (Romano et a 1
1975). Altered cell surface charges (Stratton et
a 1 , 1973) produced by treatment with papain may
also be responsible for these findings. Recently
it has been suggested that papainisation of the
red cell target increases fluidity of red cell
membrane structures so that the anti-D can bring
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about a re-distribution of the red cell surface
D-antigen/antibody complex in localised
aggregates, which appears to be necessary for the
interaction between target red cells and
lymphocytes in promotion of ADCC (Shaw et a 1 ,
1980). It has been adequately confirmed that the
surface receptor for the Fc portion of Ig (FcR)
is involved in effector functions such as ADCC
(P e r1m a n n et a 1 , 1976; Lamon et a 1 , 1975, 1976,
1977; Urbaniak, 1979b, Perlmann and Cerottini,
1979) or inhibition of T or B cell proliferation
in certain in vitro systems (Moretta e t a 1 ,
1977a, 1979). That lymphocytes have a strong
affinity for those complexes was first demon¬
strated by Uhr and Phillips ( 1 966 ) and Ba sten et
a 1 (1972). Antigen-antibody complexes, aggre¬
gated IgG and, at times, IgG itself were shown to
bind to lymphocytes by rosette formation with
antibody-coated erythrocytes , autoradiography and
immunofluorescence. Since a requirement for
binding was an intact immunoglobulin-contained Fc
piece it was assumed that the binding lymphocytes
contained Fc receptors (Basten et al , 1 97 2 ; Grey
e t a 1 , 1972). Although it is clear that most
lymphocytes with Ig receptor are much more active
in binding than those without (Basten et a 1 ,
1972; Dickler and Kunkel, 1972; Cline e t a 1 ,
1972; Yoshida and Henderson, 1972; Brown and
Greaves, 1974), the distribution of Fc receptors
on B cells, T cells and thymus cells varies from
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one report to another (reviewed by Dickler,
1976 ) .
The Fc portion is required in ADCC since its
removal from the antibody results in the loss of
ADCC activity (Ewald et a 1 , 1976). Pape et a 1
(1977 a, b) observed that effector cells (K)
involved in ADCC are Ig negative and FcR positive
and that the Fc receptors on Ig positive cells
were qualitatively different from those on K
cells. Similarly Kay et a 1 (1977), working with
peripheral human blood cells, reported that
natural killer (NK) cells and effector K cells in
ADCC are overlapping a population of FcR positive
T lymphocytes. Horwitz et a 1 ( 1 9 7 7 ) have also
shown that FcR positive cells are effective in
ADCC, whereas FcR negative cells are ineffective.
These observations are in agreement with those
that heat aggregated (MacLennan, 1972; Wisloff et
a 1 , 1974; Urbania k, 1979b) and chemically aggre¬
gated (Speigelberg et a 1 , 1976) preparations of
IgG markedly inhibit ADCC.
It has also been shown that ADCC lymphocytes lack
detectable membrane Ig determinants (Perlmann et
a 1 , 1972) and expressed either T cell (Perlmann
et a 1 , 1 97 5 and West et a 1 , 1 978 ) or null markers
(Ozer and Strelkawskas, 1979). Further, Ross and
Lambris (1982) suggested that the small number of
Ig negative CR3 positive cells detected on the K
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cell represent the cells functional in ADCC. It
has been established that monocytes, macrophages
(Lo Buglio et al , 1967) and lymphocytes
(Urbaniak, 1976; Shaw et a 1 , 1978; Kurlander e t
al, 1978) are capable of mediating lysis of human
red cells coated with antibody. However,
destruction by all these effectors is markedly
inhibited by unbound fluid-phase I g G (Lo Buglio
e t a 1 , 1 96 7 ; Shaw et al, 1978; Kurlander et a 1,
1978) and this inhibition has engendered doubt
about the role of these effectors in vivo, since
the amount of Ig G that effectively inhibits
target cell destruction in vitro is far less than
is present in serum (Shaw et a 1 , 1978, Kurlander
e t a 1 , 1978). However, Urbaniak (1979b) has
achieved satisfactory lysis by lymphocytes of
sensitized red cells in the presence of 40% human
serum, whereas very low concentrations of human
serum will inhibit monocyte-mediated AOCC of
human red cells (Holm et a 1 , 1974 and Shaw et a 1 ,
1978) and also inhibit monocyte immune adherence
of antibody-coated red cells (Abramson and Schur,
1972). Kurlander and Rosse (1979) demonstrated
that by the addition of purified monoclonal IgG^
(1000 ^g/ml) to the lymphocyte ADCC culture
medium, the lysis was markedly inhibited. In
contrast, in the presence of undiluted human
serum lysis was equal to, or greater than, lysis
in ADCC culture medium alone even in the presence
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of IgG^ at 1000 /ml - despite the high concen¬
tration (6000-19000 ^g/ml) of IgG in human serum:
i e the lymphocyte's ADCC system is inhibited by
purified fluid-phase IgG, but not by serum I gG.
Urbaniak (1979b) and Kurlander and Rosse (1979)
have suggested that lymphocytes may play a more
important role in in vivo destruction of red
cells of patients with immune haemolysis than has
previously been appreciated.
It has been noted recently that in vitro expres-
sion of ADCC may be influenced by suppressor
lymphocytes (Pollack and Emmons, 1979) and there
is some evidence that this effect may be mediated
by soluble factors (Madhavan and Schwartz, 1981).
There are also data available which indicate that
ADCC activity can be influenced by cytokines such
as interferon (Herberman et a 1 , 1979), although
no effect was seen by Kimber and Moore (1981)
when they used purified lymphocytes in ADCC cul¬
ture. A variety of agents that can influence
intracel1ular levels of cyclic AMP or cyclic GMP
are known to influence expression of Fc receptors
by T cells (Gupta, 1979). Since it has been
shown that the T cell bearing Fc receptors for
IgG is capable of effecting ADCC (Shaw et a 1 ,
1979; Katz and Fauci, 1980) these agents may
alter K-cell activity. Indeed recent work (per-
*
sonal communication M McCann, 1984) has shown
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that agents which raise intracellular cyclic AMP
depress AOCC while agents which raise cyclic GMP
enhance.
Some cell mobility would appear to be necessary
to account for the number of red cells lysed per
effector cell. Estimates of K cell numbers are
of the order of 1% to 10% of mononuclear cells
(Bib e r f ei1d et a 1 , 1975) and it has been
calculated that up to 40 red cells could be lysed
per K cell (Urbania k 1979b). The divalent
2 + 2 +
cations Mg and Ca are not required for
rosette formation between IgG-sensit i zed red
cells and mononuclear cells (Lay and Nussenzweig,
1969), and have also been shown to be unnecessary
for K cell recognition and binding to the target
(Zie g1e r et al, 1977). However, these cations
are necessary for lysis but it is not clear why
this is so: they are necessary for phagocytosis
but this is not an essential pre-requisite for
ADCC lysis of targets. It has been suggested
that they may be required to trigger intra¬
cellular events analogous to secretion of
proteins from cells or lymphocyte transformation
(Urbaniak, 1979b).
1.2.2 Role of antibody in ADCC
It has been reported that monocyte-mediated
antibody-dependent haemolysis was not only
largely dependent upon the amount of antibody
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fixed to the target, but also varied with yet
undefined properties of the antigen, the
antibody, or both (Kurlander et al , 1 9 78 ).
Likewise, there are data suggesting that the
effectiveness of antisera in producing lympho¬
cyte-mediated lysis may also depend upon the
sub-class and strength of the antiserum, the
number of available antigen sites on the red cell
membrane, and on other qualitative properties
(Handwerger e t a 1 , 1978). Kurlander e t a 1
(1979) have suggested that the degree of cell
destruction by lymphocytes depends upon the
concentration of antibody on the surface of the
red cell (target cell); lysis may be detected at
levels of anti-D coating less than 2000 molecules
per red cell.
1.2.2.1 Requirement for various portions of the
Ig molecule
Binding via the Fc receptor of lympho¬
cytes depends on the immunoglobulin
class (Basten et al, 1972). Removal of
the Fc fragment by pepsin digestion of
the sensitizing antibody was found to
reduce ADCC significantly (Gelfand e t
a 1 , 1972; Moiler and Svehag, 1972). The
nature of the trigger to lysis is un¬
known but the activated Fc-portion of
cell-bound I g G is an essential factor
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(Larsson et al , 1 973 ; Ewa 1d et al, 19 76 ;
Urbaniak , 1979b).
An obvious question is where on the Fc
portion of the Ig G is the peptide
sequence responsible for the reaction
with Fc receptors? (Fig 1). It is
reasonably well established that the
chains of I g G are folded into compact
domains, each corresponding to one of
the regions apparent in the primary
structure (Cathou and Dorrington, 1975).
Although the Fc-portion appears to be
responsible for non-specific biological
activities of the I g G molecules, the
site involved in each of these may not
be the same. Plasm in cleavage, which
removes the terminal 107 amino acid
residues, was shown by MacLennan (1972)
to reduce the ability of antibody to
mediate ADCC, suggesting that the C p 3
domain is required. However, Wisloff et
a 1 ( 1 9 7 4 ) found that the Fch fragment
containing a portion of the N-terminal
part of Fc-inhibited ADCC against
chicken red cells was better than the
C-terminal half of the Fc fragment,
suggesting that the Cy2 region is more
important to the reaction. The reason
for the discrepancy between these two
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studies is not clear. MacLennan's study
employed Chang target cells, while the
latter report used chicken red cells as
targets. Perhaps different portions of
the Fc fragment activate different
effector cell mechanisms.
Treatment of sensitising I g G with 2 -
mercaptoethanol to cleave disulphide
bonds in the Fc portion of the heavy
chain also reduced ADCC (Denk e t a 1 ,
1 9 74 ). Removal of one of the antigen-
binding sites did not prevent cytolysis,
however, when chicken red cells were
used as targets. (Michaelsen e t a 1 ,
1975).
It has been suggested that these studies
indicate that the necessary structural
features are not solely within the Cy3
domain, and that C y 2 structural
integrity is also required, either to
stabilise Cy3 or to enhance the affinity
of Cy3 for the effector cell membrane
receptor. (Reviewed by Lovchik and
Hong, 1979). Similarly Spiegilberg et
a 1 ("1 976 ), who investigated the
reactivity of human Ig G portions with
K-cells in ADCC suggested two binding
sites, one having triggering (enhancing)
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activity located on the C}'2 domain and
one having high affinity-binding located
on the C y3 domain (Figure 1). The
complexity of Fc regions expressing
biological functions is further evi¬
denced by the failure of either the Cy2
or Cy3 domains of I g G, to bind the Fc
placental receptor. It was suggested
that the Cy2 and Cy3 domains may contri¬
bute to the formation of a co-operative
binding site through quaternary inter-
domain interaction. It may be that the
Fc site responsible for different func¬
tions of lymphocytes is also different
(reviewed by Weigle and Berman, 1979).
1.2.2.2 Antibody class and subclass
Antibodies capable of triggering the
ADCC response were found to elute
predominantly with the IgG-rich fraction
rather than the macrog1obu1in fraction
of a Sephadex column (MacLennan et al,
1969; Moller and Svehag, 1972).
Recently, Urbaniak (1979b) has reported
that only I g G is effective in inhibiting
K cell lysis and that Ig A and I g M at
concentrations normally found in plasma
are ineffective, and indicated that the
lymphocyte K cell receptor - and not I g A
or IgM - is specific for the Fc portion
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of I g G. It has been shown that
aggregated Ig G has "activated" Fc
regions to bind more firmly to Fc
receptors of mononuclear cells than does
monomeric I g G (Dickler and Kunkel, 1972;
Urbaniak, 1979b), and it has been seen
to inhibit more efficiently than
equivalent amounts of native I g G
(Urbaniak, 1979b). Further, all four
sub-classes of human I g G, when
aggregated, were able to inhibit the
reaction - presumably by competing with
the antibody complexed to target cells
for Fc receptors on the effector cells
(MacLennan et al , 1973; Perlmann et a 1 ,
1972). Attempts to rank the sub-classes
with respect to inhibitory capacity have
produced variable and conflicting
results (MacLennan et a 1 , 1970; Chapuis
and Brunner, 1971; Greenberg et a 1 ,
1973; 1975; Larsson et a 1 , 1975). Some
differences may be related to the use of
different species of antibody and
effector cells. For example, using
human myeloma proteins Wisloff e t a 1
(1974) and Larsson e t a 1 (1975) found
chicken red cell lysis to be inhbited by
I gGand IgG? to a much greater extent1 3
than by Ig G ^ and I g G ^. Using Chang
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cells as targets, however, MacLennan et
a 1 ( 1 97 3 ) found that all four subclasses
inhibited lymphocyte cytotoxicity.
Moreover, the same myeloma proteins
ranked differently in inhibiting
lymphocyte effector cells than they did
when monocyte cells were the effectors
(L a r s s o n et a 1 , 1975). Spiegelberg et
a 1 ( 1976 ) have reported that
preparations of I g G ^ and I g G ^ markedly
inhibited ADCC, while I g G ^ and IgG^ were
less effective. More recently Urbaniak
( 1 979b) demonstrated that all three I g G
sub-classes caused inhibition ranked in
the order IgG^ > Ig G ^ > I g G 2 » when a
homologous system is used in the ADCC
assay.
The amount of antibody required to sen¬
sitize target cells is very small.
Under standard conditions, 50% lysis of
chicken red cells can be obtained with
as little as 0.1-1.0 ng of Ig antibody
(P e r1m a n n et a 1 , 1972). This amount is
too low to activate complement and
indicates the great sensitivity of ADCC.
More recently Urbaniak (1979a) has
reported significant lysis with an IgG
anti-D concentration of 0.02 Mg/ml (3.0
ng per culture) using human red cells as
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targets in an ADCC assay. The demon¬
stration of ADCC activation by non-
complement fixing antibodies I g G 2
(L a r s s 0 n et a 1 , 1974) and Rh blood group
antibodies (Holm e t a 1 , 1974; Urbaniak
1976, 1979a, 1979b; Kurlander _e_t aj_,
1978, Kurlander and Rosse, 1979; Kimber
and Moore, 1981) increases the potential
biological spectrum of activity of such
antibodies in immune mechanisms.
Furthermore, Urbaniak (1979a) has noted
that there was no correlation between
anti-D lytic potential (in terms of %
specific lysis of red cells) and
haemagglutination titres, and that there
was no correlation between the source of
anti-D (ie pregnancy-induced or
deliberate immunization) and the %
specific lysis. He suggested that this
disparity between the agglutinating
ability of anti-D and lytic potential
may have importance in vivo, and it is
conceivable that the ADCC assay will
predict the severity of in vivo
haemolysis better than conventional
serological techniques. This discrep¬
ancy between agglutinin titre and the
level of ADCC has been noted by other
workers (Lajos et a 1 , 19 7 9 ).
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1.2.3 Participation of Complement
Perlmann and Holm (1969) found that concentra¬
tions of anti-serum which were too dilute to
cause target cell lysis in the presence of
complement were even more effective in mediating
cell -induced lysis than were higher concen¬
trations. Also, complement-dependent lysis '\v a s
more rapid than ADCC. These findings suggested
that complement is not involved in ADCC, at least
not in a conventional manner. Others found that
caragheenan, which binds the first component of
complement, did not inhibit ADCC (Dennert and
Lennox, 1972; Dickmeiss, 1973; Pollack and
Nelson, 1973; Gale and Zighelboim, 1975). This
did not rule out involvement of the alternative
complement pathway, however (Lovchik and Hong,
1 979 ). Van Boxel et a 1 ( 1 974 ) found that both
serum and cells from animals genetically defic¬
ient in fourth, fifth and sixth components of
complement were fully effective in inducing ADCC.
However, co-operation between antibody and
complement in vivo is possible to make the
binding of effector to target cell more
efficient, since target-bound complement is
itself unable to induce cytotoxicity but enhances
ADCC at low antibody concentrations (Perlmann et
a 1 , 1975; Lustig and Bianco, 1976). In the
presence of antibody to the target cell, target
cell-bound C3 fragments strongly enhanced ADCC
(Ghevrehinet et a 1 , 1979; Perlmann and Cerottini,
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1979). It was concluded that the target cell-
associated C3 amplified ADCC by improving
effector cell-target cell contact. Recently,
Perlmann et a 1 (1981) have reported that the
activity of lymphocytes functional in ADCC was
greatly enhanced by target cell-bound complement
in the order of C3bi > C3d > C3b.
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1.3 Rh haemolytic disease of the newborn
In vivo haemolytic disease of the newborn (HDN) is the
most complex of the three common forms of IgG-mediated
red cell destruction (HDN, autoimmune haemolytic
anaemia ' AIHA1, haemolytic transfusion reactions) since
it involves the production of antibody in one individual
and cell destruction in another. The concentration of
all four I g G subclasses has been found to be slightly
higher in cord serum than in maternal serum (Mellbye and
Natvig, 1973). However, it is known that I g G ^ crosses
the placenta early in pregnancy; that by 20 weeks
gestation maternal I g G ^ is detectable in cord serum; and
that by 26 weeks gestation the cord serum level equals,
or exceeds, the maternal serum level (Morell et a 1, 1971
and Schur et a 1, 1973). In contrast, the level of I g G ^
in cord serum does not reach the maternal level until 28
to 32 weeks gestation, and it may never rise higher than
that of maternal serum during pregnancy.
Schanfield (1977) has reported that, in general, cases
of HDN caused by I g G ^ anti-D involve more serious
anaemia than those caused by *9^ anti-D. This
presumably reflects the longer exposure of foetal red
cells to IgG^ than to IgG^ anti-D. However, in cases of
HDN caused by IgG^ anti-D the infant's post delivery
bilirubin level often exceeds that seen in infants
suffering HDN caused by Ig G ^ anti-D. This presumably
reflects the fact that once it reaches the infant's
circulation, IgG^ anti-D causes a greater amount of red
cell destruction than does the I g G ^ type. However, it
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has been reported that there is no correlation between
the subclass patterns of I g G anti-D antibodies and the
degree of illness of the child ( v a n t veer-Korthof et a 1,
1981)
1.3.1 Prediction of the outcome of Rh haemolytic
di_seas_e _of _t he new born
Prediction of the probable outcome is currently
based on a number of factors:
1) The outcome of previous pregnancies
gives some indication of expected
severity, especially when the father is
homozygous for the Rh(D) antigen
(Bow man, 1978).
2) Estimation of maternal anti-D levels
during the course of pregnancy also has
predictive value, but antibody titres
are not always helpful and it is not
possible to compare results between
centres due to lack of standardisation.
Automated estimation of anti-D by
continuous-flow analyser gives more
accurate measurement of change, and
comparison with national or
international standards allows
standardisation of the assay (Mor1ey et
a 1 , 1977). Recent studies have shown
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that R h ( D ) positive babies will be
affected by HDN if the anti-D level is
greater than 5 iu/ml (equivalent to l/ug/
ml), and thereafter the prognosis be¬
comes worse with increasing anti-D
levels (Tovey and Haggas, 1971; Fraser
and Tovey, 1976 ; Tomlinson et a 1, 1981;
Bow e11 et a 1 , 198 2).
Amniocentesis and optical density
measurements (aOD 450) of amniotic fluid
also give indications of the progress of
the pregnancy and when intrauterine
transfusions should be considered
(Liley, 1963). Combined estimates based
on previous history, anti-D levels and
serial amniocentesis can enable
prediction of the outcome in approxi¬
mately 95% of cases (Bowman, 1978).
Nevertheless, unexpectedly mild (or
severe) cases can occur when using these
methods of prediction. When a high
level of anti-D justifies amniocentesis,
but the foetus is shown to be only
mildly affected, there is a risk of
stimulating further anti-D production as
a result of accidental foeto-materna 1
haemorrhage. Conversely, a low level of
anti-D may allay suspicion until it
becomes apparent that the foetus is
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already severely affected. Recently
Urbania k (1978) suggested that the
ability of an anti-Rh(D) antibody to
induce K-cell lysis may be a more
important consideration than the
strength of the antibody as determined
by conventional titration methods, in
predicting the severity of HDN that the
antibody will cause.
1.3.2 Management of Rh HDN
The discovery of the cause of Rh haemolytic
disease of the newborn (HDN), and the development
of a world-wide prophylaxis programme, is a
unique illustration of modern day preventive
medicine at its best (Robinson, 1983). Between
1940 and 1970 dramatic progress was made in
reducing mortality from this disease from 50% to
5-9% of all perinatal deaths (Tovey, 1982).
Contributory events were the development of
Coombs' antiglobulin technique, the use of
exchange transfusion between 1940 and 1950, the
advent of amniocentesis and controlled premature
delivery between 1950 and 1960, and the
development of intrauterine transfusion (IUT) by
Liley (1963).
However, despite this dramatic reduction in
incidence, cases of Rh HDN still occur. These
are due to already immunized women embarking on a
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subsequent pregnancy, failure to administer
anti-D after an abortion, amniocentesis or normal
delivery, or to failure of the anti-D
immunoglobulin to protect when given correctly.
Unfortunately, once sensitisation has occurred
the alio immunized pregnant woman has few thera¬
peutic options open to her. Currently there are
two therapeutic procedures available: plasma
exchange and intrauterine transfusion (IUT).
Intrauterine transfusion is not without risk, and
with the reduced incidence of the disease the
procedure is likely to become more hazardous as
fewer skilled exponents of the art will be
available (Palmer and Gordon, 1976; Robertson et
a 1 , 1976; Berkowitz, 1980). IUT is not possible
before 24 weeks gestation and if attempted before
26 weeks the risks are high (Berkowitz, 1980).
Plasma exchange (PE) is a relatively non-
hazardous alternative, the objective being to
remove specifically the causative antibody (Ig G
alloantibody) (Reviewed by Robinson, 1983).
Whether or not this can be done successfully on a
long-term basis during pregnancy without the aid
of immunosuppression is another matter (Urbaniak,
1984). If PE is carried out with a large enough
volume and often enough then reduction in anti-D
levels can be achieved. However, this may
require PE three or more times a week throughout
the pregnancy (Fraser et a 1 , 1 976 ; Graham-Pole et
a 1 , 1977; Robinson and Tovey, 1980), and rapid
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rebound of antibody levels cannot always be
controlled even with daily P E , in which case
foetal death results .
Although at first sight intensive PE in women
immunized to Rh seems entirely rational, and
might be expected to lead to substantial lowering
of the concentration of anti-Rh in the foetus in
utero, results have in fact been very variable
(Mollison, 1983). PE is not to be undertaken
lightly in cases of HDN because the mother is
being subjected to an arduous procedure designed
to protect the foetus, and a number of maternal
deaths have been directly attributed to PE with a
large volume of fresh frozen plasma (F F P)
(Huestis, 1983). Robinson (1983) and Urbaniak
( 1 984 ) have recommended that PE should only be
considered under the following conditions:
(i) There is a previous history of foetal
loss or a very severely affected infant,
and there is a strong possibility that
the father is homozygous for the Rh(D)
antigen;
(ii) PE should be started early in pregnancy,
and potentially immunizing effects (such
as amniocentesis) should be avoided
until 26-28 weeks, as IUT cannot be
carried out safely before then;
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(iii) Consideration should be given to prema¬
ture delivery after 31-32 weeks, rather
than attempting IUT (depending on the
facilities available).
Because immunosuppression cannot be used there is
a risk of rebound synthesis of anti-D (Barclay e_t
a 1 , 1980). In an attempt to reduce this, efforts
have been made to maintain total I g G levels with
transfusions of FFP, although this may be
associated with a high incidence of allergic
reactions, including severe anaphylactoid
reactions (Urbaniak, 1984). Paradoxically, it
has been reported that FFP may result in boosting
of anti-D levels if plasma from Rh (D) positive
donors is used, due to contaminating red cells
(McBride etal, 1978, 1983; Robinson, 1983).
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1.4 Immunization of Rh negative male volunteers
The use of passively administered antibody to prevent
primary immune induction has gained wide acceptance for
the prophylaxis of Rh immunization. Since the number of
sensitized women during pregnancy has diminished due to
the successful programme of prophylaxis, it has become
necessary to recruit and immunize male volunteers in
order to maintain a satisfactory input of plasma for the
production of anti-D immunoglobulin. It has long been
apparent that it can be very difficult to stimulate
formation of anti-Rh in some Rh-negative subjects,
despite repeated injections of Rh positive red cells,
about one third of Rh-negative subjects failing to form
anti-Rh (Mollison, 1967). A large primary dose is
chosen because a more satisfactory response is obtained
with large doses of red cells (Cook I A, 1971; Cook K,
Rush, 1974; Pollack e t a 1 , 1971). It has also been
shown that Rh-negative subjects who have failed to
respond to a small dose (0.01 ml) of Rh-positive cells
will not subsequently respond to a larger one (10 ml)
(J a k o b owic z et a 1 , 1972). A number of different
immunization schedules have been investigated (Gunson et
a 1 , 1976; Ekland, 1978; Cook et a 1 , 1980). One of the
most successful, in terms of the proportion of subjects
in which anti-D responses were induced (responders), is
that used in the Edinburgh Regional Blood Transfusion
Centre (Urbaniak and Robertson, 1981).
There still remain several unanswered questions
concerning those individuals who fail to make any
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detectable anti-D (non-responders) when subjected to
this intensive immunization regimen. It would be a
considerable practical advantage if it were possible to
identify such non-responders before, rather than after,
attempting i minun i z at i on . The immunological basis of the
response to the R h(0) antigen is not known and currently
there is no test which can distinguish responders from
non-responders prospectively. Barclay (1980) observed
certain changes in intrinsic lymphocyte transformation
(LT) and also (Barclay et a 1 , 1979 ) in the extrinsic
effects of sera on LT, which are associated with
immunization or regulation of immune responses.
Preliminary observation also indicated that lymphocyte
antibody-dependent eel 1-mediated cytotoxicity (ADCC)
might also show changes following immunization
(Urban i a k , 1977).
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1.5 Aims of the study
Urbaniak's (1979a) observations suggested that varia¬
tions exist in the degree of anti-D ADCC activity
related to the source of the anti-D (ie pregnancy-
induced or the result of deliberate immunization) and
that ADCC activity does not correlate with conventional
haemagg1utination assays.
It was therefore decided:
i) to study in detail the potential lytic activity
of anti-D sera from different sources, employing
a standardised homologous ADCC assay; and
ii) to determine whether a correlation exists between
this activity and the outcome of pregnancies
affected by HDN.
Lymphocytes are the source of both humoral (antibody)
immune response and the regulatory activities which
govern the expression of specific immune responses, so
study of intrinsic lymphocyte ADCC activity in vitro
should give an insight into the mechanisms which operate
in vivo during the deliberate immunization of Rh(D)
negative male volunteers to produce anti-D immuno¬
globulin for prophylactic use.
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The intention was thus:
i) to improve the accuracy of prediction and thus
the management and treatment of severe haemolytic
disease of the newborn resulting from R h(D)
isoimmunization in pregnancy; and
ii) to determine whether any differences could be
demonstrated between eventual responders and





2.1 Preparation of lymphocyte suspensions
2.1.1 Source of lymphocytes
Peripheral blood lymphocytes (PBL) were obtained
from blood donors and laboratory personnel in
good health and on no medication were used as
normal K-cell donors. Other lymphocytes were
obtained from male volunteers who were undergoing
plasmapheresis for the production of anti-D for
therapeutic use, pregnant women undergoing plasma
exchange to reduce maternal anti-D concentrations
in severe haemolytic disease of the newborn
(HDN ) .
2.1.2 Mononuclear Separation
Blood collected in universal containers with 10
unit/ml preservative-free heparin was layered
over an equal volume of Fico11-Triosi1 (specific
gravity 1.077 - see 2.1.3 below) and centrifuged
at 400 xg for 40 min at room temperature.
Mononuclear cells were collected at the interface
of the plasma and the F i co11 - Tr i os i 1 (Fig 2).
The mononuclear suspension was diluted to a
convenient volume with tissue culture medium 199
(TC 199 Gi bco-Bi ocu 1 t) and centrifuged at 400 xg
for 20 min. The supernatant was discarded and
the cell pellet resuspended gently in 10-20 ml TC
199. This was then centrifuged at 200 xg for 10









F13.2. Separation of mononuclear cells
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preparation. The cell pellet was then resus-
pended gently in TC 199 containing antibiotics
and 10% group A3 serum to a convenient volume for
application to a nylon wool column (2.1.5 below).
The viability of the cells vas checked by Trypan
blue dye exclusion and was always > 95% and
usually > 99%.
2.1.3 Preparation of _Fi_co 11-Tri_os_i_l_
Solution A: 9% Ficoll
90g Ficoll (400000: Pharmacia) was dissolved in
1000 ml sterile distilled water and kept at 37°C
i n a w ater bath.
Solution B: 33.9% Triosil
200 ml Triosil 440 (Nyegaard & Co) was made up to
445 ml with sterile distilled water.
960 ml solution A was mixed with 400 ml solution
B and the specific gravity adjusted to 1.076-
1.078. The mixed solution was distributed into
medical flat bottles in volumes of approximate 1 y
75ml each. These were sterilised by autoclaving
for 10 min at 1150C and then stored in the dark
at 4°C .
2.1.4 Preparation of TC 199/10% A3 serum
In all the experiments the basic tissue culture
medium (Gibco Biocult) contained Earle's salts,
25mmol/l Hepes buffer, .1 mg/ml L glutamine,
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supplemented with 10% group AB serum + 100 //I
penicillin G and 100 /uq/ml streptomycin (Difco TC
pen/strep).
Group AB serum was obtained from blood donors and
checked for the absence of red cell antibodies by
incubating 2 drops of serum with 1 drop of a
5-10% suspension of target cells at room
temperature and at 37°C for lh, then centrifuging
at low speed. Lack of haemolysis or aggluti¬
nation was observed macroscopica 11y. The AB
serum was then heat-inactivated at 56°C for 30
min to destroy complement activity, and stored in
10 ml volumes at -40°C until required.
2.1.5 P repa rat i on of ny 1 on _w ool__col_umn
The required amount of nylon wool (Tuko-pak,
Fenwal Laboratories Ltd, approx 500 mg) was
soaked in TC 199 to exclude air and then packed
into a 10 ml syringe (Plasti-pak) with a 3-way
tap at the nozzle ( Pharmasea 1 ). The nylon wool
was pushed tightly down the syringe to remove
further any trapped air bubbles, then teased out
to give a 1oosely-packed column. This was washed
through with 20ml TC 199, followed by 20-30 ml TC
199/10% AB serum. The top of the 10ml syringe
was sealed with parafilm (American Can Company)
and then incubated vertically for lh at 3 7 0 C to
allow equilibration. After washing with
pre-warmed TC 199 the column was ready for use.
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2.1.6 Removal of monocytes by nylon wool column
The mononuclear cell suspension in 2-3 ml of TC
199/10% A8 serum was added to the column and the
top sealed with Parafilm. The column was then
incubated horizontally for 30 min at 37°C in an
incubator. It was then rotated through 130° and
incubated for a further 30 min. The non-adherent
cells were e1u t e d in a vertical position with
pre-warmed TC 199: 20 ml was found to be
sufficient to recover more than 90% of the
non-adherent cells (Fig 3).
The cells ware recovered by centrifugation,
washed twice in TC 199 and finally re-suspended
at the desired concentration in TC 199/10% AB
serum. The viability of the red cell suspensions
was between 95-99%.
The average recovery of lymphocytes was 54% and
the degree of monocyte contamination was 0-1.5%
(Urbaniak, 1979a), as estimated by the
non-specific esterase method using a-naphyl
butyrate as substrate (Li et a 1 , 1 973 ).
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2.1.7 Lysis of contaminating red cells
Occasionally, when there was residual red cell
contamination of the mononuclear cell suspensions
prepared as above, it was important to remove
these red cells. This was done by hypotonic
lysis:
Composition of lysis medium:
Ammonium chloride 8g/1
Tri-sodium EDTA lg/1
Potassium dihydrogen phosphate 0.lg/1
In sterile distilled water
The cell pellet was incubated with 2 ml of the
lysis medium for 5 min at 4°C, followed by the
addition of 10 ml TC 199 and then centrifugation.
Two further washes in TC 199 were carried out
prior to re-suspending the mononuclear cells in
the appropriate medium for further experiments.
Viability was always > 95%.
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2. 2 Identification of lymphocytes
The mature lymphocyte is normally seen in two forms in
peripheral blood: the small lymphocyte (lO^m) and the
less numerous large lymphocyte (15-20(um). The nucleus
is usually spherical but may show a slight indentation
on the side of the greatest mass of cytoplasm. It can
be difficult to distinguish large lymphocytes from
monocytes (15-20(um) on the basis of morphology alone,
although the monocyte's nucleus is larger, slightly
eccentric, irregular and deeply indented or
horseshoe-shaped^ suggesting an aerial view of a
mountain range. Three methods were applied to make sure
of the absolute number of lymphocytes in the final ADCC
culture. (Adherent monocytes were removed by a nylon
wool column in all the experiments).
2.2.1 Phase-co_ntrast mi croscopy
g
One drop of cell suspension (approx 5 x 10 / ml)
was used to fill the chambers of a Neubauer
haemocytometer which was examined under
phase-contrast light at the highest convenient
magnification. The granular cytoplasm of
neutrophils and monocytes shows up clearly in
contrast to that of lymphocytes, which have a
much lighter and more uniform appearance. Since
the nuclear morphology can also be seen,
neutrophil polymorphs are easily recognised. The
percentage of lymphocytes was estimated from a
count of at least 200 cells.
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2.2.2 Toluidine blue staining
The supravital stain toluidine blue is taken up
by living cells so that cytoplasmic and. nuclear
morphology may be clearly distinguished.
Slides were prepared by making a 5 g/1 suspension
of toluidine blue in absolute methanol, adding
one drop to a clean dry microscope slide,
followed by drying at 37°C in an incubator. A
thin deposit of toluidine blue remained so that
one drop of cell suspension could be added
directly to the prepared dried slides, gently
mixed, a cover slip added, and the cell
suspension examined after allowing 2-3 min for
the cells to take up the dye. The percentage
lymphocytes was assessed by counting at least 200
cells.
2.2.3 Latex particle phagocytosis
Monocytes can be identified following the
ingestion of a suitable indicator material.
Latex particles {l/um diameter; Dow-latex) are
convenient in that they are inert, readily
phagocytosed and can be easily identified within
the cell under 1 ight-microscopy. Two or three
drops of a 1 in 100 dilution of latex suspension
(as obtained from the manufacturer) were added to
each 1 ml of TC 199/10% AB serum containing
mononuclear cells at 5-10 x 10®^mixture
was incubated at 37°C for 30-60 min with frequent
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mixing. Excess latex particles were removed by
washing in TC 199. The cells were examined under
light microscopy, monocytes being identified by
the presence of latex particles within the
cytoplasm. Neutrophil polymorphs also ingest
particles but they were distinguished from the
monocytes on the basis of nuclear morphology,
lymphocytes not showing ingested particles. The
percentage of monocytes was calculated from a
count of at least 200 cells.
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2.3 Preparati on of human C.ed_cel_1_s
Venous blood samples were obtained from normal donors or
laboratory personnel of known ABO and Rh groups. The Rh
types were confirmed by routine blood bank methods.
Blood was collected into storage medium (as used at the
Central Laboratory of the Netherlands Red Cross,
Amsterdam), 1 volume to 9 volumes of blood, and then
stored at 4° until required. Blood stored in this way
was suitable for the lytic assay for up to 3 weeks, and
up to 5 weeks for other purposes (Urban i a k, 1979a).













Nine volumes of whole blood were added to one
volume of storage medium, mixed by inversion and
stored at 4°C until required.
2.3.2 Papainisation of red cells
Five drops of red cell suspension (stored as
above) were mixed with an equal volume of 10 g/1
papain in sterile saline (BOH Papain, papaya) for
4 min at room temperature. The cells were then
washed four times in 10 ml saline, re-suspended
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and counted. Papainisation of red cells was
51
carried out prior to Cr labelling to avoid
unnecessary handling of radio-active material.
2.3.3 Labelling of RBCs with ^*Cr
20 x 10^ papainised red cells in 100 /j,] normal
saline were incubated at 37°C for lh with 200
51 51
/uCi Cr (Na Cr 04-CJS4, Amersham, adjusted to
50 u C i per 10 /i\ with sterile saline) with
51
frequent mixing to allow maximum Cr uptake by
the cells. After incubation, the red cells were
washed x 4, re-suspended in 10 ml TC 199/10% AB
serum and adjusted to an appropriate
concentration for the ADCC assay.
5 1
Cr-labelled papainised red cells were used in
all the ADCC assay experiments.
2.3.4 Pre-sensitisation of red cells with anti-D
Target cells pre-sensitized with anti-D were
prepared as follows:
Labelled papainised red cells were suspended to a
5
concentration of 8 x 10 /ml, to give an
effector/target cell ratio of 10:1 (see below).
50 ^1 of anti-D serum were added to target cells
(50 ^1) in a microplate (96-well round bottomed
plates, "Removawell", Dynatech) and incubated for
lh at 37°c in an incubator. The cells were
washed four times with TC 199, centrifuged in
microplate tray holders, and the red cell pellets
b/
re suspended using en orb itel mi oropiate shaker.
Red cells were pelleted in the wells by
c e n t rif u g a tio n a nd the s u p e rn a t an t a were
discarded and blotted from the inverted plates.
The pellets were re-suspended in 50 jul of TO
199/A3 serum for the ADCC culture (see 0.5.1
b e 1 ow ).
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2.4 Preparation of antisera
2.4.1 Source of anti-0 s e ra
Several packs of citrated plasma were obtained by
plasmapheresis from a donor SL (Mrs S Louden) who
aborted due to haemo lytic disease of the newborn
as a result of anti-D immunisation. Despite the
relatively low amount of anti-D in this material
as determined by routine methods (see below) the
biological potency of the antibody had been
proven (Urbania k, 1976-1979). This material was
therefore used extensively as a biological
control for the ADCC assay.
Other anti-D containing sera were obtained from
routine samples received in blood transfusion
centres for ante-natal screening during
pregnancy, or from male and female volunteers who
were undergoing plasmapheresis for the production
of anti-D for therapeutic use or plasma exchange
to reduce maternal anti-D concentrations in
severe haemolytic disease of the newborn (HDN).
Plasma was converted to serum by the addition of
one drop of thrombin solution (Parke-Davies) per
ml of plasma. After incubation at 37°C for one
hour the material was centrifuged and the clear
supernatant transferred into clean sterile
containers. The serum was then heat-inactivated
at 56°C for 30 min to destroy complement
activity. The specificity of the anti-D was
confirmed by testing against a panel of
standardised red cells by conventional saline,
enzyme and indirect antiglobulin methods and by
an automated continuous-flow method using
TM
Technicon Auto A na 1y s e r a p pa r a t u s and quan¬
titation technique modified from the method of
Gun son et a 1 ( 1 972 ) by pre-treat ment with enzymes
of the red cells and omission of the bromelin
line, an equivalent volume being rjn a 1 o a g </ it h
the methyl cellulose in that line, which was
increased in size. The National Institute of
Biological Standards and Controls standard an t i - 0
(code no 72/229) was used for calibration. A
conversion factor of 5 iu = 1 ^ g was used (Gunson
and Thomas, 1979).
2.4.2 Other sera con t a i_n i n g red cell antibodies
These sera were obtained from routine samples
received in the blood transfusion centre for
ante-natal screening, or from donors and patients
with pre-formed antibodies of known specificity.
In each instance the specificity of the
antibodies was checked against a standard red
cell panel using methods appropriate to that
antibody, and the titre checked using a known
positive-reacting red cell.
All sera were heat - inactivated at 56°C Tor 30 min
and stored at -40°C until required.
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2.4.3 Absorption of anti-D sera
Group 0 Rh negative (rr) and 0 Rh Positive (R ^ R ^ 1
red ceils were washed in normal saline and
hard-packed by centrifugation. One volume of
anti-D serum (2-3 ml) was added to an equal
volume of packed red cells of each ph en oty pe,
incubated for lh at 37°C in a shaking water bath,
c e n t rif u g e d and the supernatant removed. The
cells were washed three times in normal saline
and dispensed for subsequent recovery of anti-D
by elution and anti-D specific binding studies
(see 2.4.4 and 2.4.5 below). The bulk of the
supernatant was again incubated with an equal
volume of packed red cells in an attempt to
maximally deplete sera of residual anti-D.
2.4.4 Preparation of anti-D e1uate
Eluates were prepared by adsorbing specific
anti-D on to group 0 R ^ R ^ red cells (as in 2.4.3
above) and recovering the anti-D by acid elution
from red cell stroma, according to the method of
Jenkins and Moore (1977).
Briefly, this procedure follows the same general
principles as the standard method of Kochwa and
Rosenfield (1964) except that table-top
centrifugation is used in place of high-speed
spins, and pH and ionic strength are rapidly
corrected with concentrated phosphate buffers in
place of overnight dialysis.
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Reagents :
Washed red cells (see above)
Digitonin suspension
0.1 mo 1/1 glycine-HCl, pH 3.0
0.8 mo 1/I K2 NaP04, pH 8.2
Procedure:
1.0 ml of packed red cells, 9.0 ml of normal
saline and 0.5 ml of Digitonin were mixed well
and allowed to stand for 3 min before
centrifuging for 5 min and the supernatant
removed. The stroma were washed with saline
until free of haemoglobin (4 washes) and 2.0 ml
of glycine-HCl added to the packed stroma which
was mixed well and allowed to stand for 1 min.
After further centrifugation for 5 min the
supernatant was removed and 0.2 ml of K^Na P0^
added. After centrifugation to clear the
precipitate the supernatant eluate was removed
and tested.
2.4.5 Anti-D specific binding to D-positive red cells
This was measured by an immunoradiometric assay
12 5
(IRMA) employing I-labelled anti-human IgG.
Radiolabel1ed anti-IgG:
Affinity-purified rabbit anti-human Ig G (a gift
from Dr S Moore, Regional Blood Transfusion
Centre, Edinburgh) was labelled with 1 2 5 ^
(Amersham International) after the method of
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Hunter (1978), employing a 1:3:6 ratio of
protein: chloramine-T:sodium metabi-sulphite, by
weight in 0.02 mol/1 Tris buffer at pH 7.4,
purified on a Sephadex-A50 column (Pharmacia) and
eluted with 0.01 mol/1 Tris HCI.
Human group OR^R^ red cells were used for
specific anti-D binding studies and group Orr red
cells to measure non-specific background binding.
Red cells in microplates (as above) were p r e -
incubated with 1% bovine serum albumin (BSA) in
phosphate-buffered saline (PBS) at pH 7.2 with
lg/1 sodium azide added, for a minimum of 4h at
room temperature. Washes and dilutions were
performed in 1% BSA/PBS/azide with 0.01% Tween-80
added. Red cells were pelleted in wells by
centrifugation and supernatants were removed and
blotted from inverted plates, followed by re-
suspension of red cell pellets using an orbital
microplate shaker after each wash and before
adding anti-sera.
Red cells were dispensed at 10 million/ well on
microplates and washed x 3 (100 ^1/well). Anti-D
dilutions were added at 100 ul/well, followed by
thorough mixing, and the plates were incubated
for 18h at room temperature. Following 4 washes,
1 ? R
I-labelled anti-IgG was added (100 ^1/well)
and the plates incubated for a further 90 min at
room temperature followed by 5 washes. Residual
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12 5
I radioactivity associated with red cell
pellets was determined by counting individual
wells in a gamma-counter. All tests were
performed in triplicate and the results expressed
as means of the three readings.
2.4.6 Anti-D Fc-receptor activity
Red cells (Group OR^R^) were washed in PBS. One
volume of packed red cells was mixed with an
equal volume of anti-D serum (serum from a group
AB Rh positive donor being used as a control) and
incubated at 37°C for lh. The sensitized red
cells were washed 5 times in TC 199 and made up
as a 2% suspension. Washed peripheral blood
mononuclear cells were incubated with latex for
phagocyte identification (Urbaniak et a 1 , 1 9 7 8 )
and made up to 3 million/ml in TC 199 for
Fc-rosetting. Equal volumes of red cells,
lymphocytes and heat-inactivated foetal calf
serum were added to round-bottomed tubes
(Luckham, LP3), pelleted by gentle centrifugation
(150xg), incubated at 37°C for 15 min, and
incubated on ice for 60 min. Cell pellets were
gently re-suspended by aspiration. Mononuclear
cells were stained with dilute acridine orange
and lymphocyte rosette proportions (at least 2-3
red cells adhering) were determined in wet
(covers!ip) preparations viewed by incident
fluorescent microscopy with background-trans¬
mitted red illumination.
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2.4.7 IgG subclasses of anti-sera
Ant i sera to I g G ^ , I g G ^ » I 9 G ^ anci I 9 G 4 > suitable
for use in agglutination assays were purchased
from the Central Laboratory of the Netherlands
Red Cross, Amsterdam.
Anti -D sera:
Volumes of the same D-positive (0 CDe/ CDe) red
cells used for ADCC assays were washed three
times with normal saline, suspended to 5-10% then
incubated with equal volumes of doubling dilu¬
tions of anti-D serum at 37°C for lh in a water
bath or an incubator. After four washes in
normal saline the sensitized cells were adjusted
to a 2-5% suspension in low ionic strength
saline. A 1 in 20 dilution of each anti-IgG
subclass serum was prepared in 1% saline albumin.
Equal volumes of red cell suspension and Ig G
subclass serum (20 ^1) were incubated at 37°C for
15-30 min in a 75 x 10 mm glass tube, pelleted by
gentle centrifugation and the end-point
agglutination determined macroscopically. Rh(D)
negative (Orr) cells processed identically were
used as a negative control.
Anti-c sera:
These w e~ e treated as for anti-D (see above)
except that c-positive red cells (0 cde/cde) were
sensitized by anti-c, and Rh(c) negative cells (0
CDe/CDe) used as the negative control.
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2.4.8 Enrichment and depletion of serum IgG
Anti-Rh(D) sera were treated with ammonium
sulphate (using the method of Heide and Schwick,
1978 ) or po1yethy1 ene - g1yco1 (PEG) 4000 (using
the methods of Iverius and Laurent, 1967 and
Poison and Ruiz-Bravo, 1972) to precipitate serum
I g G.
PEG Precipitation :
PEG 4000 ( 1 . 5g) was added to 50 ml of serum at
4°C, with constant stirring, to give a 3% (30
g/1) solution. After stirring for 60 min, the
precipitate which formed was collected by
centr i fugation at 1800 xg. A further 6g of PEG
was then added to the supernatant while stirring
to give a 15% (150 g/1) solution. The precipi¬
tate which formed after 60 min was again
collected by centrifugation. This IgG-enriched
fraction was re-dissolved in 50 ml saline (9 g/1
Nacl ) .
Ammonium sulphate precipitation:
Ammonium sulphate powder was added to 50 ml serum
to give a final molarity of 1.82 (approximating
to 45% saturation with ammonium sulphate). The
solution was kept at room temperature overnight
and the precipitate then collected by centr~ifug-
ation (as with PEG precipitation) and dissolved
in 50 ml saline. Both precipitate-solution and
supernatant serum were dialysed against several
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changes of saline at 4°C for 3 days. The
precipitate solution was labelled "IgG-enriched
fraction" and the supernatant "IgG-depleted
serum".
IgG-enriched fractions (PEG or ammonium sulphate
methods) contained >90% of original serum I g G as
measured by nephelometry.
2.4.9 Dilution of anti-Rh sera for culture
Anti-D or anti-c sera were diluted with heat-
inactivated red cell antibody-free sera from
normal group AB donors, so that final total
immunoglobulin concentrations were comparable for
each dilution of the anti-sera.
50-^1 of diluted antibody was added at three
times the desired concentration to ADCC cultures
to produce in each case a final volume of 150 ^1.
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2.5 Culture conditions for ADCC assay
All the experiments were set up in triplicate and
including the following controls:
5 1
i) Cr-labelled papainised red cells in TC 199/
5 1
10% AB serum, to assess spontaneous Cr
release.
51
ii) Cr-labelled papainised red cells in the
presence of anti-sera, to assess potential
cytotoxicity .
5 1
iii) Cr-labelled papainised red cells in distilled
51
water or 1% Triton X, to assess maximum Cr
release possib1e.
51
i v) Cr-labelled papainised red cells without
sensitising antibody, in the presence of the
effector cells to assess any direct cyto¬
toxicity.
The test cultures contained a known number of
51
Cr-labelled papainised target red cells (usually group
0 R
^ R ^ ) , a known number of lymphocyte effector cells
with the effector/target (E/T) ratio usually 10:1, and
anti-D sensitising antibodies. The anti-D was either
added directly to the cultures at the beginning of the
incubation period as a known amount of serum, or used to
pre-sensitize the papainised target cells as described
above.
The ADCC cultures were set up in microplates (96-well
round-bottomed "Removawell" plates, Dynatech) which
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could be processed and centrifuged as a single unit.
The culture conditions involved incubation of the cell
mixture at 37°C in a humidified atmosphere containing 5%
C^/air for 15-18 h (overnight).
2.5.1 ADCC assay
Effector and target cell suspensions were pre¬
pared as above and adjusted so that the final
concentration of effector cells was 8 x 10^/ml
51
and that of the Cr-labelled papainised target
5
cells was 8 x 10 /ml. 50 ^1 of effector cell
suspension was dispensed (using a micropipette)
5
to give an E/T ratio of 10:1 with 4 x 10
4
effector cells and 4 x 10 target cells per
culture. If anti-D pre-sensitized target cells
had been prepared the culture volume was made up
to 150 ^1 by the addition of 50 ^jl of TC 199/10%
AB serum. If anti-D was to be added directly to
the culture then the appropriate dilution of
serum was added in 50 fj 1 amounts to the
appropriate cultures to give a final volume of
150 /(] .
4
The lower limit of 4 x 10 red cells was chosen
as the minimum number which gave satisfactory
total counts of r with minimum spontaneous
^Cr release (Urbaniak, 1979a).
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51 51
The sponteneous Cr release and maximum Cr
4
release consisted of 4 x 10 red cells in 150 ju\
of TC 199/10% AB serum or distilled water. The
microplates were sealed with self-adhesive sheet
(Linbro) to minimise evaporation and then covered
with a plastic lid (Removawe11). Effector and
target cells were brought into contact at the
beginning of incubation by centrifuging the
mic roplate at 200 xg for 10 min in microplate
tray holders (MSE) followed by incubation at 37°C
in a humid 5% Co^/Air incubator for 15 -18 h
(overnight).
After incubation the plates were centrifuged for
5 min at 400 xg as above and 100 /u\ of super¬
natant removed by a micropipette into LP3/tubes.
The radio-activity was assessed as below.
2.5.2 Assessment of cytotoxicity
5 1
The principle of the cytotoxic assay is that Cr
is incorporated into the red cell and bound
irreversibly to intracellular proteins (Bunting
5 1
et a 1 , 1963). Furthermore, the Chromate ion is
5 1
converted to Chromic ions which are then
impermeable to the cell membrane. Extracellular
5 1
release of Cr therefore represents a breach in
the red cell membrane and this has been taken to
represent cell lysis. It has been shown that %
red cell lysis correlates with % ^ C r release
under the culture conditions used (Urbaniak,
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1979a). The various controls described above
51
were used to estimate spontaneous Cr release
51
and maximum releasable Cr. This was compared
5 1
with the Cr release from red cells in the
presence of effector mononuclear cells, with or
without antibody.
5 1
The % Cr release was calculated as follows:
volumes of cell-free supernatant collected as
51
above were asssessed for Cr activity using a
gamma-counter adjusted to maximum sensitivity for
5 1
this isotope. The total supernatant Cr
activity was assessed by multiplying the super¬
natant fluid count by a factor of 1.5 (100 /j 1
volumes from a total of 150 ^1 culture).
Spontaneous release controls and maximum release
controls were incorporated with every experiment
and the degree of specific lysis of
antibody-sensitized red cells was calculated and
expressed as percent specific lysis as shown
b e 1 ow .
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% specific lysis =
51 51
(% Cr release in test culture)*-(% Cr spontaneous r e 1 e a s e ) +
x 100
(% maximum 51Cr release) +-(%51Cr spontaneous release)
51
The spontaenous Cr release was usually similar
in TC 199 alone or with anti-D containing
material, in which case the average was used for
calculations: if the spontaneous release was
significantly higher in the presence of any
material other than TC 199 the higher value was
used in the calculation of % specific lysis.
* Effector cells + red cells (with or without
anti-D)
+ Red cells + TC 199 (or anti-sera) - see
text
+ red cells + distilled water, or 1% saponin
H A P T E R
RESULTS
n
3.1 Characteristics of standard ADCC assay
In a biological system one inevitably finds variation
between one individual and another, and within the same
individual on different occasions. In the present study
it was necessary to minimise errors and variability due
to the technique itself, and also to know the magnitude
of these errors in order to interpret differences
observed during i n vitro investigations into the
activity of the lymphocyte (K-cell) on the lytic
potential of the antibody in the ADCC assay. Therefore
the anti-D serum of S Louden (SL) was used as a
biological control for all the experiments, since it has
been shown that this antibody has high biological
potency (Urbaniak 1979 a, b).
3.1.1 Specificity of lysis of D-positive red cells by
anti-D (SL)
Anti-D serum (SL) was diluted with AB serum in an
ADCC assay standardised at an E:T ratio of 10:1
and the results are shown in Fig 4. A dose-
response type curve was obtained with a gradual
decrease of per cent specific lysis to a barely
detectable level at 1 in 96 (the end point).
This suggests that at this point there are in¬
sufficient anti-D molecules per red cell to in¬
duce K-cell lysis. The anti-D concentration of
this particular serum, when undiluted, w.as deter¬
mined by an automated continuous-f1 ow method to
be in the region of 6 iu/ml. A dilution of 1 in
96 in the final culture therefore indicates
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SPECIFICITY OF LOUDEN'S ANTI-D LYSIS OF D-POSITIVE









O OR-^R^ + anti—D
■ OR-|R-| + AB serum
• Orr + anti—D
t Orr + AB serum
E:T ratio 10:1
1/12 1/24 1/48 1/96





activity at approximately 0.06 iu/ml (0.01 ^g/ml )
with a maximum of 97% specific lysis seen. It is
interesting to note that the antiglobulin titre
of this anti-D serum was only 1 in 16 but it
could be diluted up to 1 in 96 in a test for
K-cell lysis.
As shown in Fig 4, group Orr red cells were not
lysed in the presence of anti-D (ie they gave the
expected reactions of a negative control) and
showed similar % specific lysis in anti-D or in
antibody-free group AB serum. The degree of
specific lysis was similar to that seen with
effector cells and D positive red cells in the
presence of antibody-free AB serum (ie only
background release). Similar results were
obtained when anti-D serum (S L) was used
undiluted (ie 1 in 3 in the final culture) with
effector: target ratios of 10:1, 5:1, 1:1, 1:5 and
1:10 using cells from the same lymphocyte donor
(Table 4).
3.1.2 ADCC lytic activity of anti-D (SL) using various
effector:target cell ratios
Effector cells were obtained from ten healthy
individuals (members of the laboratory staff),
five males and five females of different blood
groups (Fig 5). The anti-D was used undiluted
(giving a final dilution of 1 in 3 in the final
culture) and this gave maximum % specific lysis




































































at E:T ratios of 10:1, 20:1, 30:1 and 40:1
respectively. The anti-D was therefore assumed
to be present in excess. It can be seen that a
sigmoidal dose-response type of curve was
obtained from the mean % specific lysis at each
E:T ratio for the ten individuals. There was a
relatively linear increase in specific lysis with
the increase in the number of effector cells,
over the range of E:T ratios from 1:5 to 10:1
4 4
(0.8 x 10 to 40 x 10 mononuclear cells per
culture). Very little lysis was seen below 1:5,
'where presumably the effector cells were unable
to lyse sufficient numbers of red cells in the
5 1
presence of anti-D (SL.) to give Cr release
above background spontaneous release. A plateau
effect began to appear at an E:T ratio of 10:1
with maximum % specific lysis at a mean of 89.9 -
9.57. There was no significant difference
between E:T ratios of 40:1, 30:1, 20:1 and 10:1
(p > 0.05), but there was a significant
difference between E:T ratios of 10:1 and 5:1,
1:1, 1:5, 1:10 (p < 0.000 1 Spearman rank
correlation .
3.1.3 Specificity of antibody and antigen for ADCC
lysis
To show that anti-D (SL) is specific for
D-positive red cells, and that anti-c (obtained
from a donor with a history of pregnancies
affected by haemolytic disease of the newborn) is
Anti-D(SL)Neat1i3thefi lculture)
Healthyindividuals(5ma eandfe )t sterioueffector/ argetr i . Fig.5
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specific for c-positive cells, controls set up
were Orr (cde/cde) and OR-^R^ (CDe/CDe)
respectively (ie cells expected to give negative
reactions with the two antibodies). Lymphocytes
were obtained from four healthy individuals of
different blood groups. The effector/target cell
4
ratio was fixed at 10:1 (4 x 10 red cells in the
final culture).
As shown in Tables 4 and 5, group Orr red cells
were not lysed in the presence of anti-D and
5 1
effector cells, and gave a similar Cr release
whether in anti-D or in antibody-free group A8
serum. The degree of specific lysis was similar
to that seen with effector cells and D-positive
red cells in the presence of antibody-free A3
serum (ie only background release). The same
pattern of reaction (no lysis) was seen with
anti-c when OR^R^ cells were used as a negative
control .
It is also interesting to note that homozygous
(D/D - c/c) red cells gave better specific lysis
than did heterozygous cells (OR^r, D/d - C/c) in




Specificity of antibody for ADCC lysis
E:T Lymphocyte % Specific Lysis with
Ratio Donor Anti-D Anti-c
* Group Orr OR^ 0R1R1 Orr 0R:r 0R1R1
10:1 A rr 7 83 96 92 85 1
10:1 0 rr 3 78 89 88 80 -1
10:1 B R2r 4 59 75 79 70 2
10:1 0 RiRi 6 81 90 87 78 5
E:T 10:1 (4 x 10^ effector ceils in the final culture)
51
(A negative value indicates that Cr release in the test sample was
lower than the control value and the ADCC activity was effectively
zero).
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3.1.4 Intrinsic K-cel1 activity of normal individuals
in the ADCC assay
During the course of preliminary experiments
defining the effector cells in the ADCC assays it
was noted that certain individuals gave
consistently good or poor responses in terms of %
specific lysis obtained under standard
conditions. It has been noted that females have
lower K-cell activity than males when human
lymphocyte target cells are used (Kovi tha vongs e_t
a 1 , 1974, Trinchieri et a 1 , 1977) but there is no
sex-linked difference in intrinsic K-cell
activity with human red cell targets
(Kovithavongs et a 1 , 1 9 7 5 ).
3.1.5 Influence of donor sex and age on ADCC
Effector cells were obtained from 120 individuals
(68 males and 52 females). Laboratory personnel
and blood donors in good health and taking no
medication were used as normal donors, with ages
between 19 and 62 years and of different blood
groups. The assay systems were comparable with
E:T ratios of 20:1, 10:1, 5:1, 1:1 and 1:10, and
with an excess of anti-D (SL) serum and group
0 R
^ R ^ target cells. Results shown in Fig 6 were
obtained from the first test on each donor.
Individual variations were noted but no
significant differences in the mean values were
found when males were compared with females
512020Numbertested 20110=15:M;5OEffector:targetratio 80420.84xlO^1effectorculture flnti-D(SL)Meat1i3thefi lculture)
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o o
(Table 6), suggesting that effector cell
capability in mediating cell lysis is independent
of the donor 1s sex.
3.1.6 Evaluation of K-cell activity in males and
females over different periods of time
Twenty females and 22 males (age range 25 to 44)
were selected at random from the same group of
120 normal individuals. Sixteen of the females
who were menstruating normally and with ages
between 19 and 35 years were evaluated on a
sequential basis to analyse the effects of time
and hormonal changes on K-cell activity, each
donor being tested at least once a week. The
assays were standardised with E:T ratios of 20:1,
10:1, 5:1, 1:1, 1:5, 1:10 and an excess of anti-D
(SL) serum, OR^R^ cells being used as target
cells. Tables 7 and 8 present the mean percent
specific lysis of each donor ( - standard
deviations). From these data no obvious hormonal
influence was discernable. Comparison between
females and males of specific lysis demonstrated
no significant difference (p > 0.05 - Spearman
rank correlation). However, two out of the 42
donors (MG male and JW female) showed generally
poor K-cell activity, never reaching values of
60% specific lysis at an E:T ratio of 10:1 (Figs
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3.1.7 Comparison between good and poor K-cell activity
Two K-cell donors were selected (Tables 7 and 8)
to demonstrate the difference between good and
poor K-cell activity in terms of specific lysis.
The female (AL) and the male (MG) were tested at
intervals of two days for eighteen days (Fig 8).
Significant differences were found between good
and poor K-cell cytotoxicity at each E:T ratio (p
< 0.01 Spearman rank correlation). Also, testing
of AL on the first day of the menstrual cycle
again confirmed that there was no hormonal
influence on ADCC activity.
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Anti-D (St) Neat 1 in 3 in the final culture
E/T ratio 10:1 (4x10^ OR-jR-j red cells per culture)
Too healthy individuals (AL, good responder;
PIG poor redponder,- from Table 7 & 8) studied
at different E/T ratios over a period of time.
Fig. 8
ay
3.2 ADCC activity of anti-D from different sources
Since the preliminary experiments involved in
demonstrating the existence of ADCC among normal
individuals used only one anti-D serum (SL), it was
important to demonstrate that other sources were capable
of specific lysis of D-positive red cells.
A comparative experiment was performed with a single
K-cell donor and anti-D (SL) as a control, the only
culture variable being the source of anti-D. Eleven
samples of anti-D from women immunized during pregnancy,
and six anti-D sera from Rh(D) negative male volunteers
who had been immunized for production of anti-D
immunoglobulin, were tested for cytolytic activity.
Anti-D from the same donor was numbered 1 or 2 to
distinguish sera taken on different occasions at an
interval of 6 weeks.
The standardized ADCC assay was used at an E:T ratio of
10:1 with the anti-D used undiluted (ie 1 in 3 in the
final culture). Results are shown in Table 9. Specific
lysis of D-positive red cells occurred with all samples
tested, except those of GP and JDu (in both 1 and 2).
However, the degree of lysis bore no obvious
relationship to the concentration of the anti-D as
determined by continuous-f1ow quantitation.
Unexpectedly, it was also found that sera from females
were more lytic than those from males, despite the
findings using conventional methods.
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Table 9
ADCC activity of different anti-D sera (1)
Source of ADCC activity
Continuous-f1 cw
quantitation Manual titration
Anti-D % sp. lysis * (iu/ml) ** Enzyme I A G T
MMc (F) 69.0 5.35 16 256
SL (F) 86.5 6.00 16 16
IM (F) 89.0 6.25 32 64
HL (F) 62.0 12.10 64 256
SH (F) 65.0 13.50 64 64
LK 1 (F) 55.0 22.50 32 128
IP 1 (F) 82.0 24.40 32 128
LC 1 (F) 21.0 33.70 128 256
MG 1 (F) 75.0 35.50 128 256
VMc 1 (F) 62.0 35.55 64 128
KP (F) 38.0 69.25 128 512
GW (M) 39.2 84.95 128 512
GP 1 (M) -1.8 95.45 256 2048
WR (M) 76.6 98.55 512 1024
DS 1 (M) 75.1 117.20 256 512
JDu 1 (M) -6.0 126.20 256 1024
GR (M) 26.4 351.75 256 1024
* E:T ratio 10:1 (4 x 10^ OR R red cells per culture)
5 iu = 1 anti -D
Continuous-flcw quantitation results in rank order.
51
(A negative value indicates that Cr release in the test sample
was lower than the control value and the ADCC activity was
effectively zero).
3 I
The same comparison was repeated with a smaller number
of sera (4 from females, 5 from males) tested on the
same day with the same K-cell donor and under identical
culture conditions. Similar results were obtained, the
sera from female donors being more active than those
from males, despite their containing less anti-D as
measured by continuous-flow quantitation (Table 10). At
highest concentrations there was suggestion of prozone
phenomenon which might have caused the low ADCC activity
in male sera.
3.2.1 Comparison of male and female anti-D sera in the
ADCC assay
Results from the previous experiment suggested
that sera from females may contain less anti-D
when assessed by a continuous-flow analyser, but
were more active than sera from males in the ADCC
assay. Urbaniak (1979a) suggested that when
using an Ig G fraction of anti-D (SL) at high
concentrations a prozone phenomenon occurred
which could be due to saturation of both effector
and target cells by excess anti-D molecules. A
similar phenomenon was previously suggested by
Zeijlemaker et a 1 (1975) when using transformed
cell lines in an ADCC assay. Three experiments
were carried out, therefore, to demonstrate that
differences between anti-D sera from different




ADCC activity of different anti-D sera (2)
Continuous-flow
Source of ADCC activity quantitation Manual titration
Anti-D % sp. lysis* (iu/ml) Enzyme I A G T
Females
SL 79 16.10 32 64
IP 2 75 32.20 64 256
MG 2 82 34.70 64 128
VMc 2 60.3 32.50 64 64
Mai es
LH 12 36.0 64 256
JDu 2 -1 116.0 256 1024
GP 2 -3 130.0 256 2048
OH 1 36 2105.0 1024 62536
OH 2 42 4045.0 4096 125072
5 iu = 1 fjq anti-D
4* E:T ratio 10:1 (4 x 10 red cells per culture); anti D final
concentration 1 in 3. The same K-cel1 donor as in experiments 1
and 2, all tested on the same day.
Continuous-flcw quantitation results in rank order.
51
(A negative value indicates that Cr release in the test sample
was lower than the control value and the ADCC activity was
effectively zero).
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3.2.2 ADCC activity of anti-D sera adjusted to
equivalent concentrations
A comparison was made of the ADCC activity of a
number of anti-D sera (3 male and 5 female
donors). The sera were diluted in AB serum to
give the same concentration in the standardized
ADCC assay with an E:T ratio of 10:1 (Table 11).
The anti-D from females were all highly active in
ADCC but that from the male volunteer OH was poor
at inducing ADCC at two high concentrations (as
expressed in iu/ml).
3.2.3 Dose-response of different anti-D sera in ADCC
Anti-D sera obtained from 4 females with bad
obstetric histories, and 5 males immunized for
anti-D immunoglobulin production, were diluted in
AB serum in an identical series of ADCC cultures
to give a dose-response curve for each anti-D.
The results (Fig 9) show that at a given
concentration the anti-D from females were more
active in ADCC than those from males.
3.2.4 Comparison of ADCC activity of anti-D on pre-
sensitized red cells and free anti-D in culture
With pre-sensitization of red cells by anti-D the
majority of D-antigen sites are likely to be
occupied by high-affinity anti-D, and it was
confirmed by a haemagg1utination technique that
94
Table 11
ADCC activity of different anti-D sera adjusted to
equivalent anti-D concentration in ADCC culture"
ADCC Activity Continuous-flcw quantitation
Source of






HL (F) 85.5 23.50 3.0
IMcC (F) 85.9 33.0 3.0
SL (F) 82.4 40.5 3.0
DH (M) 64.4 194.50 3.0
OH 2 (M) 16.6 4045.0 3.0
Expt 2
SL (F) 66.0 16.10 5.35
IP 2 (F) 58.5 32.20 5.35
OH 1 (M) -3.1 2105.0 5.35
4
* E:T ratio 10:1 (4 x 10 OR.R, red cells per culture); same K-cell
donor for all tests in expts 1 and 2.
5 iu = 1 jUg anti-D
+ original anti-D concentration before dilution
++ actual anti-D concentration in culture after appropriate dilution
F = female source of anti-D
M = male source of anti-D
Continuous-flow quantitation results in rank order.
51
(a negative value indicates Cr release in the test sample was
lower than the control value and ADCC activity was effectively
zero).
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ADCC LYTIC POTENTIAL OF ANTI-D SERA FROM
DIFFERENT SOURCES
Anti-D added directly to give final concentrations
shown; E/T 10 : 1 (4 x 10^ red cells per culture)
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anti-D was bound to these cells. This suggested
"non-specific" blocking of the Fc receptors by
"irrelevant" Ig G molecules, similar to the
inhibition of Fc-rosette binding by monocytes in
the presence of a high concentration of serum
containing IgG (Abramson et a 1 , 1 970 ).
Selected anti-D sera (from 8 females and from 8
males) were added directly to the culture, and
were also used to pre-sensitize the same number
of Rh(D) positive cells, before adding the effec¬
tor cell (K-cell donor No 1). The results are
given in Table 12. It can be seen that the free
anti-D sera showed a slightly (but not signifi¬
cantly, p > 0.05) greater degree of specific
lysis than the bound anti-D. However, the most
potent sera were those from pregnancy-immuni zed
females. The experiment was repeated under the
same conditions but using a different K-cell
donor (No 2) and a smaller number of anti-D sera
(from 5 females and from 6 males) with similar
results (Table 13). It can be seen that the
first K-cell donor was, in general, more active
than the second .
3.2.5 Comparison between pregnancy-induced anti-D and
anti-D produced by deliberate immunization
Anti-D sera from 4 male volunteers undergoing an
immunization schedule were compared with anti-D
taken during pregnancy from 4 females. These
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Table 12
ADCC activity of anti-D sera - pre-sensitized onto red






* % Specific lysis with
Pre-sensitised free serum
red cells ** anti-D*** IAGT
MMc (F) 5.35 75.0 72.0 256
SL (F) 6.00 77.0 80.0 16
IM (F) 6.25 79.0 90.0 64
HL (F) 12.10 45.0 52.0 256
IP 1 (F) 24.40 76.0 80.0 128
MG 2 (F) 34.70 72.0 70.0 256
VMG (F) 35.55 55.0 61.0 128
GMcB (F) 39.50 60.5 56.0 256
JA (M) 32.80 0.0 -1.0 256
JM (M) 80.0 23.0 30.0 512
GP (M) 95.45 -3.0 -3.0 2048
WR (M) 98.55 70.0 79.0 1024
DS (M) 116.20 66.0 69.5 512
JDu (M) 126.20 1.0 -1.0 1024
AW (M) 283.0 0.0 14.6 512
OH 1 (M) 2105.0 32.8 64.0 62536
+ 5 iu = 1 ug anti-D .
* E:T ratio 10:1 (4 x 10 0 R,R, red cells per culture) K-cell
donor No 1
** Target red cells pre-sensitized with anti-D sera prior to
addition of effector cells to ADCC culture
*** Anti-D sera added directly to ADCC culture (1 in 3 in final
culture)
F = female source of anti-D M = male source of anti-D
Continuous-f1cw quantitation results in rank order.
Spearman Rank correlation:
Females: % specific lysis with, pre-sensitized vs free serum p > 0.05
Males: % specific lysis w^|h, pre-sensitized vs free serum p > 0.05(a negative value indicates Cr release in the test sample was lcwer
than the control value and the ADCC activity was effectively zero).
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Table 13
ADCC activity of anti-D sera - pre-sensitized onto red













SL 16.10 53.0 68.7 64
IMcC 17.20 24.0 55.7 128
SHa 23.30 59.0 58.2 64
IP 2 32.20 34.0 68.6 256
LK 37.25 52.0 57.5 128
JMcB 39.50 27.0 30.6 256
Mai es
JA 32.80 0.0 -1.6 256
JDu 69.0 0.0 1.0 512
GK 137.0 16.0 27.5 128
GH 259.0 0.0 10.5 512
AW 283.0 0.0 14.6 512
OH 1 2105.0 13.5 64.0 62536
+ _ _
+ 5 iu = 1 antijD
* E:T 10:1 (4 x 10 0 R.R, red cells per culture) K-cel1 donor No 2
** Target red cells' pre-sensitized with anti-D sera prior to
addition of effector cells to ADCC culture
*** Anti-D sera added directly to ADCC culture (1 in 3 in final
culture)
Continuous-flow quantitation results in rank order.
Spearman Rank correlation:
Females: % specific lysis with, pre-sensitized vs free serum p > 0.05
Males: % specific lysis with, pre-sensitized vs free serum p > 0.05
51
(a negative value indicates Cr release in the test sample was lower than
the control value and the ADCC activity was effectively zero).
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females had had neither transfusion nor intra¬
uterine transfusion and produced babies affected
by HON which required exchange transfusions. The
highest anti-D levels amongst the four females
was that of ES (31.31 iu/ml). It can be seen
that the ADCC activities of anti-D from the four
females were consistently high compared to the
levels expressed as iu/ml (Fig 10). However, the
red cell specific lysis of anti-D sera from males
fluctuated (RG and GH) or were non-lytic (JDu and
GP). This again showed that anti-D lytic
activity does not correlate with anti-D
quantitation in terms of iu/ml, and also that
anti-D from females with bad obstetric histories
gave high red cell specific lysis in ADCC assays.
3.2.6 Comparison of ADCC with agglutination assays
One unexpected finding was the low ADCC activity
shown by several anti-D sera from immunized males
with very high antibody levels as determined by
continuous-flow quantitation. (Tables 9-13).
When a number of anti-D sera from immunized males
and from pregnancy-sensitized females were
diluted to equivalent continuous-flow concent¬
rations the poor ADCC activity of several sera
from male donors was confirmed (Table 11 and Fig
9). Anti-D sera were quantitated by conventional
agglutination techniques (enzyme and antiglobulin
titres; continuous-flow Auto-Analyser quantit¬
ation) and the results compared with the ability
COMPARISONBETWEEPREGNANCY-INDUC DANTI-DPRODUCED BYDELIBERATEIMMUNIZATION 100 80 60 40 20 0 -20 100 80 60 40 20 0 -20iRG(M)!GH(M ▲i i T" JLI 01234 After3rdboostJDu(M)
GP(M)






























of the same sera to mediate lysis of Rh(D)
positive red cells in ADCC assays.
Sera from 19 Rh(D) negative women immunized
during pregnancy and 17 Rh(D) negative male
volunteers who had been immunized for the
production of anti-D immunoglobulin were assayed
by conventional assays and in the ADCC assay
(Table 14). Although manual enzyme and
antiglobulin titres do not allow accurate
comparison of anti-D levels the results did show
a statistically significant correlation (Spearman
Rank correlation) with the continuous-flow
quantitation (continuous-flow vs enzyme in all
tests, P < 0.006 > 0.005; continuous-flow vs
antiglobulin in all tests P << 0.0001). Similar
results also could be obtained from Tables 10-13.
The ADCC activities of the anti-D sera did not
correlate with any of the conventional assays
(Spearman Rank correlation). Comparison of
anti-D from males with that from females showed
that in the males levels were significantly
higher when assessed by continuous-flow
estimation (P = 0.002 Wilcoxon test), yet were




Comparison of ADCC of Anti-D from different sources
with conventional agglutination assays
Continuous-f1ow
ADCC Activity* quantitation Manual titration
Source of Indirect
Anti-D % Sp. lysis (iu/ml) + Enzyme Antiglobulin
Females
McC 69.0 5.35 16 256
IM 89.0 6.25 32 64
SMcK 0.5 6.5 8 32
LC 10.0 11.9 16 256
HL 62.0 12.10 64 256
SH 65.0 13.5 64 64
SL 67.7 16.10 32 64
IMcC 36.5 17.2 64 128
SHa 58.0 23.30 16 64
SB 21.0 23.75 32 512
EMcK 15.7 28.90 32 128
IP 2 61.7 32.20 64 256
VMcC 60.3 32.5 64 64
MG 2 70.0 34.70 64 128
LK 2 57.5 37.25 128 128
GMcB 51.0 39.50 64 256
SHo 5.8 53.0 128 512
SU 20.0 54.50 256 512
MW 52.0 71.50 64 256
Mai es
AB -6.3 0.20 1 Nil
ND -4.5 16.30 16 256
JA -1.6 32.8 64 256
LH 0.0 56.0 64 256
MB 21.3 61.0 128 512
DS 2 2.5 73.0 64 128
JM 25.0 80.0 128 512
GW 39.2 84.95 128 512
GP 1 -1.8 95.45 256 2048
WR 76.6 98.55 512 1024
JDu 2 -3.0 116.0 256 512
GK -5.5 137.0 32 128
RG -0.7 206.5 512 2048
GH 0.23 259.0 256 512
AW -3.6 283.0 64 512
GR 26.4 351.75 256 1024
OH 1 32.8 2105.0 1024 62536
* E:T ratio 10:1 (4 x 10 OR.R, red cells per culture); anti-D final
concentration ig,culture I Tn 3; random K-cell donors (a negative
value indicate Cr release in the test sample is lcwer than the
control value and the ADCC activity is effectively zero).
+ 5 iu = 1 anti-D
Continous-flcw quantitation results in rank order
Spearman rank correlation:
quantitation vs enzyme (all test) 0.006 > P > 0.005
quantitation vs antiglobulin (all test) P << 0.0001
Wilcoxon test: quantitation results, males vs females P = 0.0024
ADCC results: males vs females P = 0.00023
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3.2.7 ADCC activity and IgG subclasses
The previous experiments showed that the ADCC
activity of anti-D sera did not correlate with
any of the conventional haemagg1utination assays.
It has been shown that IgG^ and I g G ^ re^ cell
antibodies are the most efficient at inducing
ADCC lysis (Holm et a 1 , 1974; Urbaniak, 1979b)
and at fixing complement and inducing immune
adherence (Abramson and Schur, 1972). The same
sera were therefore tested to determine their IgG
subclasses, to show whether there was correlation
between the lytic activity of anti-D with I g G
subclass.
«
The I g G subclass distribution of the sera is
shown in Table 15. In all the sera tested the
subclasses known to be lytic in ADCC (I g G ^ and
I g G ^) were present either together or singly, and
in all the sera from males (except that of DS)
the IgG^ titre was higher than that of IgG^
(w here present).
Sera from females were more heterogeneous but
there was a tendency for the I g G ^ titres to be
higher than those of the males when related to
the total anti-D level (iu/ml). In 18 of 23 sera
(78%) in which I g G ^ was present, and to a level
higher than I g G ^» the ADCC activity was less than
30% specific lysis, whereas in all twelve sera in
which the I g G ^ level was greater than that of
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Table 15
ADCC activity in relation to IgG sub-classes
Source of ADCC activity IgG sub-classes (titres)
Anti-D % Spec Lysis* IAGT IgG, igGo igo, I gG4
Females
i i— ■ ■"
SMcK 0.5 32 128 0 0 0
SHo 5.8 512 512 16 16 8
LC 10.0 256 16 0 0 0
SU 20.0 512 256 32 4 4
SB 21.0 512 256 4 8 4
IMcC 36.5 128 64 32 256 32
KP 38.0 512 128 0 256 0
LK 2 42.0 128 64 0 0 0
GMcB 51.0 256 128 1024 2048 1024
MW 52.0 256 256 64 512 16
SHa 53.0 64 8 256 512 64
IP 2 61.7 256 128 64 256 128
VMc 62.0 128 64 4 128 0
HL 62.0 256 64 0 128 0
SH 65.0 64 32 0 64 0
SL 67.7 64 32 16 0 0
MMc 69.0 256 32 1 128 0
MG 1 75.0 256 64 0 128 0
Mai es
AB -6.3 Nil 4 0 0
GK -5.5 128 2048 256 128 256
ND -4.5 256 32 0 0 0
AW -3.6 512 512 128 128 128
JDu 2 -3.0 512 512 64 128 32
GP -1.8 2048 128 0 8 0
JA -1.6 256 512 16 0 0
RG -0.7 2048 512 0 32 128
GH 0.2 512 2048 256 0 256
LH 0 256 512 16 0 0
DS 2 2.5 128 128 32 128 16
MB 21.3 512 128 64 32 16
JM 25.0 512 256 0 8 16
GR 26.4 1024 512 0 128 0
OH 1 32.8 62536 4096 128 512 1024
GW 39.2 512 512 8 128 8
WR 76.6 1024 512 64 128 0
* E:T ratio 10:1
** IAGT = indirect antiglobulin test (broad spectrum)
51
(A negative value indicates Cr release in the test sample was
lewer than the control value and the ADCC activity was effectively
zero)
ADCC activity results in rank order.
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IgG^ the activity was greater than 30% specific
lysis. IgG2 and IgG4 were present in anti-D sera
from both males and females, but always in
association with IgG1 and/or IgG^- There was no
obvious correlation between IgG2 and/or IgG4.
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3.3 Characterization of anti-D sera which are non lytic in
ADCC
Conventional manual and automated quantitation of
anti-Rh(D) antibodies relies upon their agglutinating
properties. The ability of such antibodies to sensitize
D-positive red cells for lysis by peripheral lymphocytes
in vitro by ADCC may be a measure of the biological
potency of anti-D in vivo: eg as in haemolytic disease
of the newborn (Urbaniak, 1978). Previous studies have
shown that the lytic activity of anti-D in ADCC is not
related to the anti-D content as measured by
conventional assays based on haemagg1utination. It has
also been found that anti-D from deliberately immunized
males generally exhibits less ADCC activity in relation
to its anti-D content (in terms of iu/ml) than do sera
from women immunized during pregnancy. Those
differences are not directly related to differences in
the I g G subclasses of the antibodies. It is important,
therefore, to attempt to characterize the factors which
determine the lytic activity of anti-D. In this
section, the characteristics and interactions of lytic
and non-lytic anti-D sera in ADCC are described.
3.3.1 Comparison of anti-D quantitation, specific
anti-D binding and specific lysis in ADCC of
anti-D sera
Anti-D sera from male volunteers were
investigated for anti-D content by conventional
continuous-flow quantitation; anti-D specific red
cell-bound Ig G by IRMA; specific ADCC by the
standardised ADCC assay; and ADCC against anti-D
pre-sensitized red cells. The results are shown
in Table 16. Eleven anti-D donors were studied,
one of them (J W) twice, on serum taken on two
different occasions, two months apart.
Three sera (GP, JW1 and JW2) were found to lack
ADCC activity in the conventional assay.
However, JW1 and JW2 showed ADCC lytic activity
in the pre-sensitization assay; only GP lacked
such activity completely and it was selected for
further study. Although JW's anti-D appeared to
retain ADCC activity in the absence of other
serum components - possibly indicating some
non-specific "irrelevant" IgG molecules to block
ADCC - further studies were carried out on this
serum, and an anti-D serum with ADCC lytic
activity from a male donor (JM Section 3.2) was
selected for comparative study.
Analysis of the overall pattern of results (Table
16) showed no significant relationship between
ADCC assays (standardised or pre-sensitization)
and either anti-D content or specific anti-D
binding to red cells (P > 0.05). However, a
significant correlation was found between anti-D
content and specific binding (P < 0.01) by bcth
normal and non-parametric (Spearman) analysis of
correlation.
Table 16
Comparison of anti-D quantitation, specific anti-D binding
and specific lysis in ADCC of anti-D sera"
A 0 C C Continuous Specific
*{% specific lysis) flew binding
pre-sensitised quantitation (IgG IRMA)
Serum free serum red cells (iu/ml + mean cpm
AA 27.0 28.2 6 6589
SW 64.3 52.9 12 6455
LK 31.7 50.3 25 8026
LH 41.5 30.4 39 23029
GP 0 0 75 35555
DH 90.2 83.9 136 43240
DH 97.4 76.9 145 59976
JM 93.5 62.0 157 47569
GM 78.1 71.9 210 46478
IM 58.4 87.0 214 52942
JW 2 0 69.9 533 69235
JW 1 0 53.3 578 67569
+ 5 iu = 1 ^g anti*D
* E:T 10:1 (4 x 10 0 R.R, red cells per culture) K-cell donor No 2
** Target red cells pre-sensi tized with anti-D sera prior to
addition of effector cells to ADCC culture
*** Anti-D sera added directly to ADCC culture (1 in 3 in final
culture)
Continuous-flcw quantitation results in rank order.
Spearman Rank correlation:
% specific lysis with, presensitized vs free serum (P > 0.05)
ADCC assays vs anti-D sera quantitation (P > 0.05)
ADCC assays vs anti-D sera binding to red cells (P > 0.05)
Anti-D sera quantitation vs anti-D sera binding to red ceils (P < 0.01)
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3.2.2 The effect on ADCC of mixing lytic and non-lytic
anti -D sera
Non-lytic serum from donor GP was mixed with
lytic serum from donor JM, and also with a second
lytic serum SL (anti-D 6 iu/ml, ADCC of the order
of 95% specific lysis). The results are shown in
Fig 11.
When equal amounts of the non-lytic serum (GP)
and the lytic serum (JM) were mixed, ADCC
specific lysis was as great as with JM's serum
alone. Reduction of the proportion of GP's serum
had no significant effect, but dilution of the
lytic serum (JM) reduced ADCC lysis gradually (ie
a dose response). However, dilution of the lytic
serum (JM) in the presence of a constant amount
of non-lytic serum (GP) demonstrated an
inhibitory effect of serum GP on the ADCC lysis
of JM's serum at lower concentrations,
increasingly moving the "dilution curve" to the
left with increasing dilution of the serum JM.
In contrast, when the non-lytic serum (GP) was
mixed with second lytic serum (SL), serum GP
having a much greater anti-D content than serum
SL, ADCC activity was completely abolished. In
this case the anti-D ADCC activity gradually
re-appeared on dilution of serum GP in the
presence of a constant amount of serum SL.
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Serum dilutions
° Lytic serum alone
• Lytic serum with constant non-lytic serum (1/10)
0 Non-lytic serum with constant lytic serum (1/10)
The effect on ADCC activity on mixing lytic and
non-lytic anti-D sera.
Fig. 11
Inhibition of the ADCC lytic activity of both
anti-Ds was thus observed when they were mixed
with an ADCC non-lytic anti-D in the appropriate
proportions. The expression of the inhibitory
effect appears to be related to the relative
anti-D content of these sera.
3.3.3 Specificity of inhibition
To investigate the specificity of the inhibitory
effects of the anti-D serum GP, 25 per well
was pre-incubated with red cell targets at 37°C
for 90 min, followed by addition of 25 //l of
ADCC-lytic anti-c or anti-D and lymphocytes to
give a final culture volume of 150 ^/I/well. In
this experiment (Fig 12) group OR^R^ (cDE/cDE)
target red cells were used. The standard ADCC
assay was used as a control with anti-c or anti-D
sera, target cells and lymphocytes, but without
adding the non- lytic anti-D sera to the culture.
It can be seen that the non-lytic serum (GP) had
no inhibitory effect on the three lytic anti-c
tested. However, in 7 of 8 anti-D sera (87%)
ADCC lytic activity was inhibited, and in 3 of 7
activity was virtually abolished. The observed
ADCC inhibiting effect of non-lytic anti-D thus
appeared to be specific for the Rh(D) antigen.
All anti-c sera tested were enhanced in the
presence of non-lytic anti-D serum.
ADCC
%specificlysisoGroup0,R2R2(cDE)dcell 100 50- 0 0Anticsera
AntiDsera
| preincubatedwithnon-lyticanti-D
Thepatt rnofinhibitionsnADCClyt cp tentialfdiffer tRan sera(-cand-D)byftDCCnon-l ticanti-(GP):relationshiptspecificity. Fig.12
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3.3.4 ADCC activity of anti-D eluates
Anti-D was specifically adsorbed onto group OR^R^
red cells from three sera from males (GP, JM and
JW2 from Table 11) and recovered by elution after
the first absorption. Absorption was repeated in
an attempt to deplete sera maximally of residual
anti-D. The specific binding patterns of anti-D
to red cells, as determined by Ig G - IRMA for
both sera and eluates, are shown in Figure 13. A
prozone effect of reduced binding at high
concentrations was found with all three sera and
this probably reflects prevention of maximal
anti-IgG binding due to rapid agglutination of
the red cells. The anti-D content of each of the
three eluates was of the same order of magnitude
and gave similar binding curves.
Neither the serum nor the eluate of GP showed
ADCC lytic activity (Figure 13), whereas both
serum and eluate of JM showed such activity. As
previously found (Table 11), serum J W 2 did not
show ADCC activity: however the eluate of JW2
was ADCC active. This appears to confirm the
observations on the serum JW2 by both conven¬
tional and pre-sensitization ADCC assays (Table
11); ie anti-D JW2 is ADCC active and that other
factors present in the whole serum inhibit its
ADCC activity.
IgG IRMA: red cell bound anti-D
1^l-anti-lgG (cpm x 10'^)
dilution of test serum
• Whole serum (o D-negative red cells )
■ Eluate
The specific binding of anti-D to red cells as
determined by IgG IRPHA for both sera and eluates;
and ADCC lytic potential of sera and eluates.
Fig. 13
3.3.5 ADCC activity of IgG fractions of anti-D sera
IgG-enriched fractions of sera GP (ADCC
non-lytic) and JM (ADCC lytic) were prepared by
polyethylene glycol (PEG) and ammonium sulphate
precipitation. IgG-depleted serum was prepared
after removal of ammonium sulphate precipitates,
followed by dialysis: (both < lg/1 IgG; < 1 iu/ml
anti-D). The relative ADCC lytic activities of
serum JM and its derivatives are shown in
contrast to the relative ADCC inhibitory
capacities of serum GP and its derivatives
(Figure 14), where they reflect each other.
Thus, in the (respective) lytic and inhibitory
sera the lytic and inhibitory activities are
reduced by (i) absorption of anti-D and (ii)
depletion of IgG: both activities are recovered
in (i) eluted anti-D and (ii) IgG-enriched
fractions.
3.3.6 Anti-D Fc receptor rosetting activities
The ability of anti-D sera to sensitize Rh(D)
positive red cells for rosetting through Fc
receptors for I g G on lymphocytes was examined.
All were capable of Fc-rosetting (Table 17). Red
cells not sensitized with anti-D sera rosetted
with less than 2% of the lymphocytes.
ADCC-inactive serum (GP) did not differ




















ADCCinhibitionandctivitybyIgGdepleted enrichedanti-Dserafrac on,anti-Dd plats rn anti-Deluotes. Fig.14
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Table 17
Anti-D Fc receptor rosetting activities
Qont-j nuous
flow
Lymphocyte-RFC Quantitation % Sp.
Serum (mean % Fc-RFC) (iu/ml)+ Lysis*
SL 24 6 97
GP 34 75 0
JM 31 157 94
JW 2 57 533 0**
* E:T ratio 10:1
** 70% specific lysis by presensitisation of red cells
+ 5 iu = 1 /ug anti-D
Continuous-flcw quantitation in rank order
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3.3.7 I g G subclasses of ADCC-lytic and ADCC-non-lyti c
anti-D sera
The relative distributions of the IgG subclasses
in ADCC-active sera and eluates from JM and S't-
were compared to those in the ADCC inactive serum
GP and in the serum JW2 (anti-D active/whole
serum inactive). The relative haemagglutination
titre endpoints with anti-subclass antibodies on
anti-D specifica 11y-sensit i zed red cells are
shown in Table 18. Anti-D I g G subclass
distributions were similar in ADCC-active and
ADCC - inactive sera. Eluates appeared to show
relative enrichment of IgG^ and depletion of 1983
compared with whole sera. It is improbable that
any redistribut i on of subclasses of serum JW on
elution was responsible for the ADCC-activity of
this eluate in contrast to the inactivity of the
serum in the standard ADCC assay, since serum JW
showed ADCC activity in the pre-sensitization
ADCC assay .
Table 18
Relative haemagglutination titre endpoints with anti-subclass
antibodies on anti-D specifically sentitized red cells
IgG Sub-classes
(reciprocal of titre) Anti-D % Sp.
Test Serum IgG—1 IgG-2 IgG-3 IgG-4 (iu/ml)+ Lysis
JM
Serum 1024 16 32 0 167 +

































donor serum 0000 0
(control)
+ 5 iu = 1 fig anti-D
* JW serum agglutinated directly to a dilution of 1 in 32
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3.4 ADCC and Rh Haemolytic Disease of the Newborn (HON)
In pregnancies where Rh haemolytic disease is suspected,
an indication of the prognosis can be obtained from the
outcome of previous pregnancies (Bowman, 1978), from
estimates of maternal levels of anti-D (Fraser and
Tovey, 1976), and from optical density measurements of
amniotic fluid which may indicate when intrauterine
transfusion should be considered (Liley, 1963).
Variations in the potency of anti-D sera in mediating
ADCC of Rh(D) positive red cells have been noted
previously (see Section 3.2) and it has been shown that
there is little correlation between conventional
agglutination assays and ADCC.
3.4.1 Anti-D lytic activity during pregnancy affected
by HDN
Samples from 8 females were taken during the
antenatal period where HDN was suspected, and the
sera were stored frozen at -40°C until tested,
when the anti-D content was estimated by
continuous-flow quantitation. The samples were
heat - inactivated (56°C for 30 min) and tested on
separate occasions but the same lymphocyte
(effector cell) and red cell (target cell) donor
was used for each patient, with anti-D (SL) as a
control to enable quantitative comparisons to be
made. The clinical details of these cases are
















PBara2+0 (noHDN) CCPara2+0 (affectedbyHDN) AO'NPara4+1 (affectedbyHDN) VMcAPara1+0 (noHDN) EBPara1+5 (affectedbyHDN) FPPara4+1 (affectedbyHDN)
Notdone Notdone Notdone Lowzone (27%)* Midzone (35)(36%) Highmidzone (29)312 (33)4 Highmidzone (26)28)(31) (32)6
13.0 (38%) 15.0 (40) Notavailable (39) 11.3 (38) 12.9 (37%) 13.2 (34%) 11.3 (38)
80 43 55 62 62 80
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PositiveExchangtransfusionSurv ved x1 PositiveNon
Survived
Positive2redcelltransfusionsSurv ved PositiveExchangtransfusionSurv ved x2 PositiveExchangtransfusionlSurvived +2redc lltransfusions PositiveExchangtransfusionSurvived x2 PositiveExchangtransfusionSurvived x3
DAGT=irectantiglobulintest thesamezon .
OD450=opticaldensitychangeatnm,re eatamniocentesispr di tionremainedw h
# weeksofgestation
Cases of HDN where amniocentesis was not
performed
In the first four cases shown in Table 19 (NC,
MD, PB and CC) HDN was suspected from the
presence of anti-D only (Fig 15). NC had neither
a previous history of pregnancy no r of blood
transfusion, but her anti-D level had risen
suddenly from 0.11 iu/ml to 7.26 iu/ml between
weeks 23 and 25 of pregnancy and then gradually
reached its highest level (15.81 iu/ml) at 32
weeks, labour being induced at 34.5 weeks. This
rise was most probably due to transp1 acenta 1
haemorrhage (TPH ) .
The anti-D of MD never reached 2 iu/ml (< l^g./ml)
during her pregnancy. That of PB gradually rose
from 0.62 iu/ml at 12 weeks and reached 10.58
iu/ml at 40 weeks. In patient CC the anti-D
level was 11.05 iu/ml at 12.5 weeks gestation and
then gradually tapered to 5.8 iu/ml at 39 weeks.
This was most probably due to the existence of
anti-D from her previous pregnancy, in which the
baby had been affected by HDN.
In general the anti-D level was not helpful in
prediction of the outcome of three of the four
pregnancies. However, the ADCC assay gave very
good correlation with the outcome in the four
cases in relation to blood transfusion. In two
















































12 16 20 24 28 32 36 40 12 16 20 24 28 32 36 40
Gestation weeks
• % Specific lysis; E/T ratio 10:1 (4 x 104O R^ R^ red cell per culture);
The same K-cell donor for all tests
O Anti-D level; 5 iu = 1 /jg
▲ SL's anti-D used as control
I Z4
cell transfusion (top-up) for anaemia, or no
transfusion at all, the anti-D potential lytic
activity in terms of specific lysis, was very
low. The other two (NC and MD) had given birth
to affected infants which required exchange
transfusion and the ADCC activities of anti-D
serum were high.
3.4.3 Cases of HDN where amniocentesis was performed
The second four cases of HDN shown in Table 19
(AO'N, VMcA, EB, FP) were tested to predict the
outcome of pregnancy by amniocentesis and anti-D
quantitation, and these results compared with
ADCC assays (Fig 16).
The anti-D levels of AO'N remained at 1.35 iu
until 27.5 weeks gestation, when amniocentesis
was performed. The anti-D then rose suddenly to
reach 13.50 iu/ml at 37 weeks and reached its
highest level (21.50 iu/ml) at 37 weeks.
Similarly, the anti-D of VMcA rose rapidly after
amniocentesis, most probably indicating secondary
immunization induced by amniocentesis. However,
in cases EB and FP the anti-D level was not
affected by the amniocentesis. Prediction of the
outcome of pregnancy using amniocentesis was not
accurate, and in the case of EB the highest
measured level of anti-D was 4.32 iu (< lug/ml)
at 30 weeks gestation. However, ADCC assays
predicted the outcome of pregnancy accurately
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12 16 20 24 28 32 36 40
■TF ■Ti^ •"fF
• % Specific lysis; E/T ratio 10:1 (4x 10^ 0 R-j R-| red cell per culture);
The same K-cell donor for all tests
O Anti-D level; 5 iu = 1 pg




where a high potential lytic activity of the
anti-D indicated a severely affected baby which
subsequently required an exchange transfusion.
3.4.4 Series of anti-D sera tested blind
Samples taken during the course of pregnancy in
cases of suspected HDN were also selected in
Glasgow and tested "blind" in Edinburgh prior to
the clinical details being revealed. Two series
of samples (11 cases) were tested on separate
occasions using the same effector cells, target
cells and anti-D (SL) as described above.
Series 1 : Sera were selected from three cases
where there were discrepancies between prediction
based on the anti-D level and the amniocentesis
results. The clinical details of these cases are
shown in Table 20. The three sera each contained
a high level of anti-D, indicating a poor
prognosis, but the amniocentesis results
suggested unaffected - or only mildly affected -
babies in each instance. The clinical outcome
showed that amniocentesis gave a misleading
prediction in the cases of RMcG and AMcA.
The ability of the anti-D sera to mediate ADCC of
ORh(D) positive target cells is shown in Figure
17. It can be seen that samples from RMcG and
AMcA were highly active and resulted in lysis
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similar dose-response curve on dilution of anti-D
in culture. The serum from AM was virtually
inactive at all dilutions tested. The severity
of HDN in each of the infants (Table 2) correlat¬
ed with those findings with the babies of RMcG
and AMcA requiring exchange transfusion, whereas
that of AM required only a "top up" transfusion
for anaemia.
Series 2: In the second series, a further eight
cases were selected on the basis of high maternal
anti-D levels (> 20 iu/ml) but these had variable
clinical outcomes, including cases where this was
better than expected on the basis of anti-D level
a 1 one.
The clinical details of the eight cases studied
are shown in Table 21. For this experiment
another two K-cell donors were used as well as
the same effector cell donor (No 1) used in the
previous study. Serum from each patient was used
neat (ie 1 in 3 in the final culture, Table 22)
and also diluted in inert (group AB) serum using
donor No 1 (Figure 18).
In five cases with high anti-D levels, amnio¬
centesis correctly predicted the severity of the
HDN. In two cases (MT, LM), despite high anti-D
levels the outcome was favourable with no trans¬
fusions required. In retrospect, amniocentesis
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Table 22
ADCC activity of anti-D sera from series 2 cases




Control JT CR FJ CS MF EK MT LM
Donor
No 1
79* 99 97 94 91 91 50 28 7
Donor
No 2
78 96 70 80 77 71 51 21 5
Donor
No 3
90 92 83 80 91 89 54 21 0
* % specific lysis, anti-D "neat" (1 in 3 in the final culture)
E:T ratio 10:1 (4 x 10 red cells per culture)
SL(control)
JToMF* CR0EK♦ FJaMTx CSaLM+
Vioioo Dilutionofanti-Dserum
flDCCactivityufnti-Dseraromsaries-2c ses EjJratio10:1(4_x0^JOR-R^parcultu e), anti-Ddilutionsshow
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would have been unnecessary. In one case (EK) a
Rh(D) negative baby was delivered despite the
amniocentesis prediction. The ADCC activities of
these eight sera are shown in Figure 18.
Very high ADCC activity was seen in the five
cases requiring intrauterine and/or exchange
transfusion, and three of these five babies died.
In all five cases the ADCC activity was greater
than that of the control (SL). In the two cases
where exchange transfusion was not required (MT,
LM) extremely low ADCC activity was seen at all
dilutions of anti-D serum and with the different
K cell donors (Table 22). In the cases with an
Rh(D) negative baby (EK) the moderate ADCC
activity represented a "false-positive" reaction
similar to the "prediction: given by amnio¬
centesis. As in the Series 1 cases, the active
sera showed clear dose-response curves.
When the ADCC activity of the undiluted anti-D
sera is correlated with the actual anti-D level
(Fig 19) both Series 1 and Series 2 cases
segregate into two well-defined groups on the
basis of severity of the HDN. It can be seen
that the % specific lysis gives better discrimin¬
ation between "good" and "poor" outcomes, than
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Further samples were provided from two cases J T
and FJ (in Table 21) during the same pregnancy
and these were tested with the same effector
cells (donor No 1). Results of the tests on
these are shown in Figs 20 and 21 respectively.
The ADCC activity of anti-D sera were consist¬
ently high, confirming the previous observations.
3.4.5 Correlation of outcome with ADCC assays in HDN
due to anti-c
Anti-c is the second most common cause of severe
HDN, after anti-D. Affected infants may require
exchange transfusion and perinatal deaths can
occur. As variations in the potency of anti-D
sera in mediating ADCC lysis correlate with the
outcome of HDN, and are therefore of value in
predicting severity of disease, it was of
interest to compare results obtained by
conventional assays with the ADCC assay in cases
of HDN due to anti-c, to determine whether a
similar correlation exists.
Anti-c sera from pregnant women were obtained
from blood samples which had been referred to the
laboratory undertaking antenatal testing. The
clinical details of the six cases selected for
study are given in Table 23. The IAGT did not
correlate well with subsequent severity of HDN.
In two cases where the titres were the same (ER





















oAnti-D level 5 iu = 1 /ig
aSL's anti-D used as control
SB = Stillbirth







































18 20 22 24 26 28 30 32 Weeks of
<>..0 gestation
Amniocentesis
• %' Specific lysis E/T ratio 10:1
OAnti-D level 5 iu = 1 m9 anti-D
▲ SL's anti -D used as control
IUD = Intrauterine death
ADCC activity of anti-0 of hJ during pregnancy
(from series-2)
Flo 21
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AP producing a baby (A CDe/cde) not affected by
HDN and ER having an affected baby which required
exchange transfusion.
ADCC activity of anti-c sera
The same six anti-c sera (Table 23) were diluted
in inert (Group AB) serum as shown in figure 22,
and tested in an ADCC assay against a c-positive
target red cell, using the same K-cell donor as
above, the sera showing ADCC activity in a dose
response manner on dilution. Very high anti-c
lytic activity was seen in five cases, the
infants of four of these subsequently requiring
exchange transfusion and one (J C) resulted in a
stillbirth. One patient (AP) had a healthy child
and this was predicted by low activity in the
ADCC assay.
3.4.6 ADCC activity and I g G subclasses of anti-c
With anti-D the I g G subclasses known to be lytic
in ADCC are Ig G ^ and I g G ^- (Section 3.2.7) The
I g G sub-classes of anti-c in the six cases
studied were heterogeneous (Table 24). However,
there was a tendency for tit res of *9^3
antibodies to be higher in three of the five
cases, which correlated with high lytic activity
in the ADCC assay. It is also worth noting that
case ER had a higher IgG^ titre than AP. There
were no obvious correlations between IgG2 or I9G4
anti-c and ADCC activity.
Dilutionofanti-c-serum
flDCCactivityofnti-c
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3.5 Rh immunization in male volunteers
In order to maintain a satisfactory supply of plasma for
the production of anti-D immunoglobulin it is necessary
to recruit and immunize male volunteers. This is
primarily due to the diminishing numbers of women
sensitized during pregnancy as a result of the
successful programme of prophylaxis against Rh(D)
immunization .
3.5.1 Immunizing schedule
Individually matched Rh(D) positive frozen/
thawed red blood cells were used to immunize
Rh(D) negative male volunteers. The immunizing
schedule (Fig 23) consisted of a single infusion
of 200 ml of frozen/thawed red cells followed,
after a six-month rest period, by six-monthly
booster doses of 0.5 to 1.0 ml using the same red
cell donor (Urbaniak and Robertson, 1981).
3.5.2 Normal values for lymphocyte ADCC
Six Rh(D) negative males were studied pros¬
pectively, four of whom had produced anti-D
detectable by continous flow analysis, following
primary immunization, and two of whom had not.
Evaluation of lymphocyte ADCCs in healthy
individuals showed that while the majority
exhibited high specific cytotoxicity (75-100%
specific lysis) in this system at a 10:1 E/T
ratio, some individuals had a lower lytic


















between ADCC activity and ABO or Rh blood groups
(Section 3.1.4). However, the lytic capacity of
each individual appeared relatively constant and
varied little on repeated evaluations over
periods up to 2 years in some cases. The six
volunteers were tested for their lymphocyte ADCC
activity using E/T ratios of 10:1, 5:1, 1:1, 1:5
and 1:10. Normal ranges of ADCC were established
for each subject by repeated testing during the 6
months prior to immunization, and these were
taken as two standard deviations from the mean
values (Table 25). In general, the cells of R2
showed higher lymphocyte ADCC activity than those
of the other subjects. R1 and R3 were studied in
greater detail (see below).
3.5.3 Changes in ADCC lymphocyte capacity during
primary immunization
Four male volunteers 1R, R3, NR2 and NR2 (Table
25) were studied from the time of primary immun¬
ization with 200 ml frozen/thawed red cells
(Figure 23). The E/T ratios were 10:1, 5:1, 1:1,
1:5 and 1:10. For simplicity, only the maximal
specific lysis at 10:1 is given (Fig 24). Anti-D
(SL) serum was used in all experiments to enable
quantitative comparisons of the lymphocyte ADCC
activity of each subject to be made. Subject R1
showed a slight transient fall in ADCC activity a
week after immunization, and this lasted for 5
weeks. Anti-D was first detected at 8 weeks. In
Table25






































































































*E:Tratio10:1(4x0edc llperul ure) +Mean-standarddevi tion
LYMPHOCYTEADCCCTIVITYINMALEVOLUNTE RS AFTERPRIMARYIMMUNIZATION
100










6 o Q <
a>
£
o o CL E
>






■R1 •R3 aNR1 ONR2
•.Normalrange Effector:targetra io10 1 _JI
012345678 Time(months) P=rimaryimmunization200lD+cells(frozen/th wed) Fig.24
147
subject R3 there was a slight short-lived drop of
intrinsic ADCC activity at 4.5 weeks, and anti-D
was first detected 13 weeks after immunization.
However, subjects NR1 and NR2 showed no change in
intrinsic ADCC activity.
3.5.4 Effect of booster doses on lymphocyte ADCC
activity
The four Rh-negative volunteers who had
detectable anti-D following primary immunization
and responded to boosting with a rise in serum
anti-D level were classed as responders (Fig 25,
R1-R4). The remaining two subjects did not
produce detectable anti-D in their serum at any
time and these were classed as non - responders
(NR1 and NR2). Peripheral blood samples for
lymphocyte and serum studies were taken from
subjects immediately prior to boosting and at
various times thereafter (always including day
7).
In both non-responders studied, no changes in
intrinsic ADCC activity were seen following
booster injections of red cells (Fig 26, NR1 and
NR2). Marked, but short-lived, depressions of
ADCC activity were seen following booster
injection in all four responders (Fig 26, R1 to
R4). Examination of ADCC activity over a range
of K-cell:target cell ratios following boosting
confirmed that there was abolition of K-cell
148
Days post boost-1
The effects of booster immunization on anti-D responses
in subjects who were successfully immunized (responders
R1-R4) Changes in serum anti-D are shown in relation












The effects of booster immunization on lymphocyte
ADCC activity in responders (R1-R4) and non-responders
(NR1 , NR2). Boosts are indicated by vertical broken
lines, and the normal ranges of each individual's





function rather than a shift in the "dose-
response" curve, and that the effect of boosting
was transient. The perturbation of ADCC induced
by boosting appeared to diminish with subsequent
successive boosts (Fig 26). However, detailed
examination of the ADCC responses at frequent
intervals following boosting indicated that with
later boosts the depression of ADCC activity was
of the same order of magnitude as with earlier
boosts, but that loss of activity occurred
earlier after the boost (Figs 27-30).
3.5.5 ADCC anti-D lytic activity
Using autologous cells:
In parallel experiments to determine intrinsic
ADCC activity of the subjects R1 and R3 in an
identical culture, each subject's K-cells were
tested with their own serum instead of anti-D
(SL). The pattern of intrinsic ADCC activity was
similar to that when anti-D (SL) was used (31,
32). This was more obvious with subject R1 than
with R3, who had a lower anti-D level than R1.
Using a normal K-cell donor:
Anti-D from subjects R1 and R3 was collected and
stored at -40°C during the immunization schedule.
These sera were tested against normal K-cells at
an E/T ratio of 10:1. Both R1 and R3 showed
marked ADCC anti-D activity after the first boost
(Fig 31-32). However, in subject R1 the activity
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started at the time of the first boost when his
anti-D level was at 92 iu/ml. On the other hand
the anti-D level of R3 at the same time was 13
iu/ml. In general, the ADCC anti-D activity of
R1 was more lytic than that of R3.
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01 2 3456789 10 11
I Days post boost
Boost
Lymphocyte ADCC activity in a responder (R1):
effect of repeated boosts at various E/T ratio.





























0 1 23 456789 10 11
t Day post boost
Boost
Lymphocyte ADCC activity in a responder (R2):
effect of repeated boost at various E/T ratio.
The usual time of assay (day 7) is indicated
Fig. 28
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01234 567 89 10 11
f Days post boost
Boost
Lymphocyte ADCC activity in a responder (R3):
effect of repeated boosts at various E/T ratio.
The usual time of assay (day 7) is indicated
Fig. 29
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01 2345 678 9 10 11
Days post boost
Boost
Lymphocyte ADCC activity in a responder (R4):
effect of repeated boosts at various E/T ratios.
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Intrinsic ADCC activities (lymphocyte and anti-D)
and anti-D level during immunization schedule in
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3.6 Antenatal plasma exchange to reduce anti-D concentration
The technique of plasmapheresis has been used for many
years to collect plasma from males and females iso-
sensitized to the Rh(D) antigen, and with high antibody
concentrations, for the preparation of anti-D immuno¬
globulin. The procedure has also been used in Rh
immunized mothers during the antenatal period, in an
attempt to reduce the level of antibody. Bowman et al
(1969) and Powell (1968) tried antenatal plasmapheresis
with equivocal results but Clark et a 1 ( 1 970 ) reported
success after combining antenatal plasmapheresis with
intra-uterine transfusion.
Plasma exchange may be more desirable than
plasmapheresis alone, since plasmapheresis merely
removes plasma while plasma exchange replaces the
patient's plasma with normal plasma: this both
replenishes plasma components and dilutes maternal I g G
anti-D relative to the total plasma immunoglobulin
levels (Powell, 1968 and Graham-Pole et a 1, 19 77).
3.6.1 Effect of plasma exchange on maternal anti-D
concentrations
The patients examined had been referred to the
Regional Blood Transfusion Centre, Edinburgh, by
local obstetricians and the clinical details are
given in Table 26.
Three of the six mothers studied had experienced
a foetal death in utero (AB, BL and MC), two had
Table26









Para4+0moderateFath r HDNUncertain Para3+2stillbirthORr Para3+0moder teOR2̂HDN
HA39YrsAr IAGT=ndirectantiglobulintes ;**5iu1pgnti—D
Gestational Age(weeksat Presentation) 27 27 27 24 25 12
PresentingAnti—DL vel
*IAGTtitreAnalyser(iu/ml) 1:64 1:28 1:28 1:024 1:32 1:024
30.70 45.50 34.50 89.50 26.50 32.85
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produced Rh(D) infants unaffected by Rh HDN (JM
and ID) and one (HA) had a baby which had
required two exchange transfusions and had
survived (Table 2 7). In each of the cases,
intensive plasma exchange was initiated at
various stages of pregnancy (Table 26) and
carried out with a continous-flow cell separator
(Aminco Celltrifuge). During each exchange an
average of 3-4 litres of maternal plasma was
exchanged with an equal volume of normal frozen
fresh plasma (FFP) and/or plasma protein solution
(PPS 5% human albumin). Plasma exchange was
undertaken approximately daily for the remainder
of the pregnancy. FFP was used from the first
day of exchange. In the first five cases the
plasma used was from donors of the same ABO
group, but not the same Rh group, as the patient;
however HA was exchanged with ABO and Rh specific
FFP. Throughout the study, anti-D levels were
measured by conventi ona.l manual methods and by
continous-flow quantitation.
It can be seen from Figs 33-37 that with daily
exchange the first five cases each showed an
initial reduction in the level of anti-D of the
order that might be expected on theoretical
grounds. After the eighth day, following initial
exchange, despite continued exchange therapy
there was an apparent increase in the level of





























































10th-18th day. In three cases (AB, BL and MC)
amniocentesis and intrauterine transfusions were
also carried out. In case 6 (HA, Fig 38) the
anti-D level was reduced and remained around 5
iu/ml until the end of the plasma exchange
therapy. Amniocentesis was performed at 32 and
36 weeks gestation, after the exchange therapy
had ended after 41 exchanges (at 31.5 weeks
gestation) .
3.6.2 Effect of plasma exchange on anti-D I g G sub-
classes (case AB )
Anti-D IgG sub-classes were studied during plasma
exchange of AB. Samples were collected before
and after exchange, as shown in Table 28, and
Figure 33-A. As can be seen, there was a
correlation between the I g G sub-class titres and
anti-D concentration. However, there was no
evidence of a qualitative difference.
3.6.3 Effect of plasma exchange on anti-D ADCC activity
Maternal sera obtained from clotted blood taken
before and after each exchange was inactivated by
heating at 56°C for 30 min and stored at -40°C
for retrospective investigation. The sera were
tested on different occasions using the same
K-cell donor (effector), the same target red
cells (OR^R^) and anti-D (SL) as a control for
all tests (% specific lysis = 86.6 - 1.5). It
has been shown that the ADCC of anti-D is
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proportional to its concentration, so that
dilution reduces the "lytic potential" in a dose
response curve. In the present study the
opposite effect was observed in three cases AB,
BL and JM (Fig 33, 34, 36), since the anti-D
lytic potential was greater after the exchanges
than before, although in the corresponding sera
the anti-D concentration had been reduced. On
the other hand the pre-exchange samples from
patients MC, ID and HA (Fig 35, 37, 38) were more
lytic than those taken post - exchange . In the
first five cases, when the anti-D level reached
its peak, the ADCC anti-D lytic activity fell.
However, in Case 6 (HA) the anti-D lytic activity
remained consistently high throughout the
pregnancy in spite of the reduction in anti-D
level.
3.6.4 Effect of plasma exchange on lymphocyte ADCC
activity
The lymphocyte ADCC activity was studied pro¬
spectively in three cases (JM, ID and HA, Table
26) during plasma exchange. Normal values were
taken from the healthy normal individuals
(females, section 3.1.4) as these patients had
not been tested prior to exchange. The
lymphocyte ADCC activity was determined before
each exchange by using column-purified peripheral
blood lymphocytes as effector cells, and 0R]_R^
target cells at ratios of 10:1, 5:1, 1:1, 1:5 and
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1:10. For simplicity, the maximum specific lysis
at 10:1 is given. Anti-D (SL) serum was used in
all experiments to enable quantitative compari¬
son .
In two cases (JM and ID) a marked, but short¬
lived, depression of ADCC activity was seen on
day 6 (Fig 36, 36A, 37A). When the lymphocytes
of patient ID were tested with her own anti-D
(the first sample before plasma exchange) on the
same day and using the same target cells, the
depression of ADCC activity was of the same order
of magnitude as with anti-D (SL).
However, in patient HA, who was exchanged with
Rh(D) negative FFP, no changes in intrinsic ADCC
activity were seen (Fig 38).
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Fig. 33
The effect of plasma exchange by FFP, unselected for
Rh group, on anti-D ADCC lytic potential and maternal
anti-D concentration.
Days on which amniocentesis and intrauterine transfusion




E:T ratio 10:1 (4x104 OR^R^ red cells/culture)
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5 7 9 11 13 15 17 19 21 Days from first
^ plasma exchange
Effect of plasma exchange on maternal anti-D concentrations
Days on which amniocentesis and intrauterine transfusion were




Effect of PIasma Exchange on Anti-D IgG Sub -classes in Case (AB)
Weeks of Autoanalyser
Gestation Anti-D ★ igs2 !gG3 igs4 IAGT
27 Pre: 30.7 128 16 64 0 64
Post: 12.0 32 8 16 0 16
27.5 Pre: 10.6 16 2 8 0 32
Post: 4.8 8 1 4 0 32
28 Pre: 6.1 32 4 16 0 64
Post: 3.1 32 4 16 0 64
28.5 Pre: 129.0 128 16 128 0 512
Post: 65.3 64 8 16 0 128
Pre: 163.0 128 16 64 0 128
Post: 65.3 64 8 32 0 64
29 Pre: 491.5 1024 128 512 0 4096
Post: 249.5 512 64 256 0 512
30 Pre: 285.0 512 64 128 0 512
Post: 147.2 256 64 128 0 128
Anti-D quantitation; 5 iu = 1 ^g.
IAGT = Indirect antiglobulin test (broad spectrum)
Pre and post-plasma exchange
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Fig. 34
The effect of plasma exchange by FFP, unselected for
Rh group, on anti-D ADCC lytic potential and maternal
anti-D concentration.
Days on which amniocentesis and intrauterine transfusion




E:T ratio 10:1 (4x10^ 0R.R.J red cells/culture)
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The effect of plasma exchange by FFP, unselected for
Rh group, on anti-D ADCC lytic potential and maternal
anti-D concentration.
Days on which amniocentesis and intrauterine transfusion




E:T ratio 10:1 (4x10^ OR^R^ red cells/culture)
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The effect of plasma exchange by FFP, unselected for
Rh group, on intrinsic ADCC activities (lymphocytes




E:T ratio 10:1 (4 x 10^ 0R^red cells/culture)





















JM's K-cell vs SL's serum (anti-D)
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ADCC ACTIVITY IIM CASE 4 (JM) DURING A
SERIES OF PLASMA EXCHANGES
1:10 1:5 1:1 5:1 10:1 Effector:Target ratio
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The effect of plasma exchange by FFP, unselected for
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ADCC ACTIVITY IN CASE 5 (ID) DURING A
SERIES OF PLASMA EXCHANGES
Q
1:10 1:5 1:1 5:1 10:1 E:T Ratio
A K-cell (ID) vs anti-D serum (SL)




Effect of plasma exchange by FFP, selected for Rh group
(Rh negative), on intrinsic ADCC activities (lymphocytes
and anti-D) and maternal anti-D concentration.
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HA's K-cell vs SL's serum (anti-D)


























HA's serum (anti-D) vs normal K-ceil donor
500
II III IIIII nil IIIIII11 III 11 III IIIIIImi I III 1111,11,1 II III IIH Illll IImill 11 III IIIIIIIIIIIII m








n m^i m rfii&n&hiih 11T* tn f *1" hTi^& i iTi





+ Rh pos baby survived






DISCUSSION AND CONCLU S I Q N S
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4.1 Introduction
The original aim of this study was to standardise
the ADCC assay in order to minimise the biological
variability in intrinsic non-adherent lymphocyte
(K-cell) activity in the general population. The 6
iu/ml anti-D (SL) was used as a control to enable
quantitative comparison to be made. For the same
reason a homologous system with group OR^R^ target
red cells was used in most of the experiments.
This system was employed to study anti-D from
different sources, and the results have thrown
light on the discrepancies in ADCC lytic potential
between anti-Ds, especially between those produced
by deliberate immunization of male volunteers and
those induced by pregnancy. These differences were
confirmed by the correlation of high ADCC anti-D
lytic potential, and severity of HDN. Changes were
also found in the ADCC intrinsic lymphocyte
activity of male volunteers during immunization,
which distinguished between responders and
non-responders of anti-D suitable for production of
therapeutic immunoglobulin. Similar changes were
noted in women undergoing therapeutic plasma
exchange to reduce maternal anti-D when FFP from
donors of different Rh groups was used.
4. 2 K-Cel1 activity
Study of the control anti-D serum SL has shown
that it is able to lyse D-positive red cells at
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different dilutions when a single effector cell
donor is used, and whether the E/T ratio is fixed
or changed (Fig 4 and Table 4). Significant lysis
was obtained with anti-D concentrations as low as
0.06 iu/ml (= 0.01 (ug / m 1 ) per culture. Detection
of activity at this degree of dilution of anti-D
makes the ADCC assay much more sensitive than the
conventional serological methods. Anti-D (SL) was
equally effective when several donors of effector
cells were employed at varying E/T ratios, with a
plateau appearing at a ratio of 10:1 (Fig 5). For
reproducibi1ity an E/T ratio of 10:1 was therefore
used for most of the experiments when the anti-D
ADCC lytic potential was tested.
In this series of experiments it was demonstrated
that Orr red cells are not resistant to K-cell
lysis, an appropriate antibody specific for these
cells (anti-c) having been included as a positive
control (Table 5 This study revealed that the
important factors (Urbaniak, 1979a) were: i) the
quantity of antibody present in relation to the
number of red cells; ii) the relative number of
effector and target cells per culture (ie the E/T
ratio); and iii) the appropriate combination of
antigen and antibody (eg D/anti-H, c/anti-c). It
was also noted that cells homozygous for D or for c
give better lysis than heterozygous cells in the
presence of anti-D or anti-c respectively, there¬
fore cells were used in the standard assay.
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Individual variation in intrinsic K-cell activity
was seen amongst members of a healthy donor popula¬
tion. One hundred and twenty healthy individuals
were tested in 496 experiments for K-cell intrinsic
activity, in an ADCC assay with anti-D serum (SL)
used in excess and OR^R^ red cells as targets (Fig
6). Titration of K-cells against a constant number
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of Cr-labelled red cells allowed construction of
dose-response cytotoxicity curves with % specific
lysis plotted against the number of K-cells.
Lymphocyte titration experiments were performed
rather than single determinations of K-cell activ¬
ity at fixed effector/target ratios, as the latter
provides only limited information and comparison
may be misleading. The use of varying effector/
target ratios allowed genuine determination of a
biological parameter [% specific lysis) which was
directly comparable between individuals (Fig 6 and
Tab!es 7 and 8).
Using the assay described in this thesis (Section
2.5.1, Urbaniak 1979a) no significant differences
were found in the ADCC activity of lymphocytes when
males and females were compared. These results
appear to conflict with those of Kovithavongs et a 1
(1974) and Trinchieri et a 1 (1977), who reported
depression of ADCC amongst normal females. The
former group reported that menstruating females had
depressed ADCC activity compared with age-matched
males, but post-menopausa 1 women were found to
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exhibit ADCC activity equal to that of males.
Kovithavongs et a 1 ( 1974) suggested that the
ability to mediate ADCC in vitro may be subject to
hormonal influences, and also reported a positive
correlation between increasing age of the donor and
strength of ADCC activity. However, 80% of the
females in the present study (Table 8) were tested
close to the first day of their menstrual cycle.
From these data neither obvious hormonal effect nor
cyclic variation could be seen. A possible basis
for the discrepancy between these results and those
of Kovithavongs et a 1 (1974) and Trinchieri et a 1
(1977) may be either: i) the presence of two
effector cells in peripheral blood which are
capable of mediating ADCC (lymphocytes and mono¬
cyte); or ii) (more likely) a difference in
target cells. Both groups of earlier workers used
h uman lymphocytes as targets, but there was no sex
difference when human red cells were used
(Kovithavongs et a 1 , 1975 ).
It has been demonstrated that K-cell activity of
normal individuals is independent of sex and age
when chicken red cells (Edwards and AVIS, 1979) and
Chang-cells are used as targets (Penschow and
Mackay, 1980). Differences in ADCC activity are
seen when target cells, antibodies and effector
cells from different species are tested in various
combinations (Zighelboim and Gale, 1974). On this
basis, Urbaniak (1979a) suggested the use of a
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homologous system for comparison. The results in
the present study suggest that the cytotoxic
capability of K-cells from,normal individuals is
independent of the age, sex and blood group of the
donors when an appropriate combination of antigen
and antibody is used. The cytotoxic capability of
K-cells was also found to be consistent in
individuals when tested sequentially. However,
significant differences were seen between different
individuals in their capability to mediate ADCC in
this system. Those who did not produce more than
50-60% specific lysis with anti-D (SL) at an E/T
ratio of 10:1 were categorised as "poor" responders
(< 2%), and those who produced more than 60%
specific lysis as "good" responders (approx 98%).
In this study better results were achieved using
OR^R^ (D/D) target cells at an E/T ratio of 10:1
and with an excess of anti-D (SL) serum, and this
combination was used for the standard comparative
experiments and the choice of good responders (as
defined above). Thus in cases where K-cell
activity was studied, lymphocytes were titrated in
a standard ADCC assay. However, where antibodies
were studied for their lytic potential activity, a
fixed number of effector cells (good responders
Figs 7 and 8) and target cells was used (E/T ratio
10:1).
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It seemed possible that this mechanism may
contribute to the in vitro lysis of red cells in
haemolytic disease of the newborn (HDN) where
anti-D is commonly implicated, and this is
discussed later in this chapter.
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4.3 IgG subclasses and ADCC activity -
The lytic capacity of the effector cell suspension
depends on a number of variables (Urbani ak , 1979a)
and those were minimised in the present
investigation by using standard assay conditions.
On a number of occasions comparative experiments
were done with a single K-cell donor, where the
only culture variable was the source of the anti-D.
Under these experimental conditions it was apparent
that the "lytic potential" of anti-D sera for Rh(D)
positive red cells in the ADCC assay did not
correlate with any of the conventional methods of
assaying anti-D (Table 14). The anti-D serum (SL)
was included in all experiments as a control for
ADCC activity of the K-cell donors.
An unexpected finding was the significantly low
ADCC activity shown by several anti-Ds from
immunized males with very potent antibodies in
terms of iu/ml (Tables 9 and 10). When a number of
anti-D sera from both immunized males and
pregnancy-sensitized women were diluted to
equivalent anti-D concentrations, the poor ADCC of
several of the sera from male donors was confirmed
(Table 11). The pregnancy-i nduced sera showed
consistently high specific lysis and it is
noteworthy that all of those women whose anti-D
showed high lytic potential had borne infants
affected by HON and who had required exchange
transfusions. The difference in lytic activity of
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anti-D from males and that from females cannot be
attributed to the absence of the I g G subclasses.
I g G ^ and I g G ^» which are known to induce ADCC lysis
of red cells (Holm et al , 1974; Urbaniak, 1979b,
Hunt et al , 1980 ) since either or both were present
in all sera. However, where the I g G ^ titre was
greater than that of IgG^ the anti-D was active in
ADCC; conversely, where the IgG^ titre was greater
than that of IgG^ the anti-D was inactive (or poor)
in ADCC (Table 15). In five sera in which I g G ^
alone occurred, ADCC activity was low in two of
three sera from females and in both those from
males. The relative proportions of anti-D
subclasses therefore appear to determine the degree
of binding of any one subclass, assuming there are
not wide differences in affinity. These results
suggest that IgG^ is more active than IgG^ in ADCC,
but the effectiveness of I g G nay be masked by
other less active subclasses. The distribution of
IgG subclasses between sera from males and from
females provides a partial explanation for the
observed discrepancies in ADCC activity. Although
high titres of IgG^ were seen in sera from males
they occurred together with high titres of less
active subclasses, 'which may have masked the ADCC
activity. These findings are in accord with those
of van der Meulen et a 1 ( 1978 ), who found that IgG^
"warm" autoantibodies to red cells were nearly
always associated with demonstrable haemolysis,
whereas IgG^ was not infrequently associated with
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normal red cell survival, and IgGg and IgG^ were
inactive.
In samples with very high levels of anti-D it was
possible that the low ADCC activity could be due to
inhibition of K-cells due to saturation of Fc
receptors by an excess of anti-D molecules (a
prozone effect). This was shown not to be the case
(Fig 9), dose-response curves of ADCC activity
correlating well with the single dilution results
(Tables 9 and 10) and also in p r e-s e ns i t i z ed red
cell ADCC assays (Tables 12 and 13).
It is possible that "non-specific" blocking of the
Fc receptors by "irrelevant" IgG molecules, similar
to the inhibition of Fc-rosette binding by
monocytes in the presence of high concentrations of
serum containing Ig G (Ab rams on et a 1 , 1970 ), could
have accounted for differences which were found in
lytic potential. In these experiments the amount
of immunoglobulin in the culture system was
maintained at a constant level by making all
dilutions of anti-D in inert (group AB) serum, thus
effectively titrating the specific anti-D but
maintaining a constant total immunoglobulin level.
Non-specific blocking is improbable since for any
given anti-D serum a constant level of K-cell lysis
was observed whether the culture medium contained
low (10%) or high (40%) proportions of the test
serum (Urbaniak, 1979a), and ADCC lysis of anti-D
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coated red cells by monocytes has been shown to
proceed in the presence of undiluted human serum
(Kurlander and Rosse, 1979).
194
4.4 Variations in activity between anti-D from
different sources
Different K-cell donors (good responders) were used
for each series of experiments and it can be seen
that consistently high or low ADCC results were
obtained with given anti-D sera, within the limits
of biological variation (eg sera of donors OH, AW,
RG, GH). Interestingly, fluctuations were noted in
the ADCC activity of most male individuals during
the course of immunization, with some lytic
activity being shown on several occasions.
In this study anti-D sera from immunized male
volunteers were compared with different anti-D ADCC
activities to attempt to identify differences
between the respective anti-D antibodies which
might indicate a basis for their different ADCC
activities. Experiments were conducted to
investigate: i) differences in specific binding to
Rh(D) positive red cells; ii) differences in I g G
composition of anti-D antibodies; iii ) differences
in interaction of anti-D sensitized red cells with
lymphocytes; and iv) factors other than anti-D
antibodies which may affect ADCC.
No differences were found in the specific binding
of the.anti-D sera to D-positive red cells when
assayed by IRMA (Table 16 and Figure 13). At an
appropriate dilution of anti-D (1 in 50) falling on
the linear portion of each serum's anti-D binding
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curve, highly significant correlation was found
between bound I g G (IRMA) and anti-D content ex¬
pressed as iu/ml. Neither IgG binding nor anti-D
content showed any correlation with ADCC, either in
the standard ADCC assay or when red cells were pre-
sensitized with the anti-Ds (Table 16), confirming
previous observations (Section 3.2.5). However, it
was noted that one individual's anti-D which showed
no ADCC activity in the standard assay (JW 1 and JW
2, Table 16) expressed ADCC activity when used to
pre-sensitize red cells. This appears to indicate
that the anti-D antibodies themselves are capable
of supporting specific ADCC, but that other factors
in this serum inhibited ADCC expression. This was
supported by the finding that the anti-D of donor
JW alone, recovered by elution after specific
absorption on D-positive red cells, showed ADCC
activity in the standard ADCC assay (Figure 13).
Two of the sera tested (JDu and GP, Section 3.2)
were found to be consistently inactive in ADCC.
the serum of donor GP was selected for further
study, together with that of a male donor with
similar content of anti-D, which showed high ADCC
activity (JM, Table 16). Studies were also carried
out on an anti-D serum which had high ADCC activity
and low anti-D content (SL), and an anti-D from a
male donor which was ADCC-inactive as serum, but
the anti-D used for pre - sensitization or as an
eluate was active (JW) .
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Serum mixing experiments were carried out to
determine the effects of anti-D sera of different
ADCC activities on the expression of ADCC. Only
inhibition was observed (Fig 11), and this appeared
to be related to the relative amounts of inactive
and active anti-D in mixtures. This indicated that
anti-D (GP) was intrinsically inactive in ADCC, and
that it inhibited expression of ADCC by other
anti-D sera by competing for D-antigen sites on red
cells. This rules out insufficiency, either in the
IgG subclasses or in the range of specificities, as
a basis for ADCC-inactivity, since any
insufficiency could have been restored by
ADCC-active anti-D sera: such synergy might have
been detected as enhanced ADCC in mixing
experiments. Competition for D-antigen sites
between ADCC-active and ADCC-inactive anti-D sera
as the basis of the observed inhibition was
confirmed by investigation of the ability of anti-D
(GP) to inhibit ADCC activities of different
anti-Rh antibodies (Figure 12). Inactive anti-D
(GP) was unable to inhibit anti-c mediated ADCC,
but inhibited anti-D mediated ADCC by seven out of
eight anti-D sera. These results also show that
the c-antigen is sufficiently independent of the D
antigen in the red cell membrane to escape
inhibition by the ADCC-inactive anti-D.
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The subsequent experiments on anti-D isolated by
absorption and elution, and on IgG-enriched and
depleted serum fractions (Figures 13 and 14),
support the conclusion that this ADCC-inactive
anti-D (GP) has IgG anti-D antibodies which are
i ntrinsically unable to collaborate with lympho¬
cytes in mediation of ADCC of D-positive red cells,
but in other respects behaves like anti-Ds which
express normal ADCC activity. As well as showing
comparable specific binding to the D-antigen on red
cells, this serum was as capable of sensitizing red
cells for rosetting with lymphocytes through Fc-
receptors as were ADCC-active anti-D sera (Table
17), and contained comparable anti-D I g G subclasses
(Table 18). This demonstrated that certain anti-D
antibodies are i ntrinsically inactive in mediating
lymphocyte ADCC or Rh(D) antibodies (whether from
de1iberately-immunized male volunteers or from
pregnancy-immunized women) which show a range of
ADCC activities.
Wide variation has been observed in the ability of
anti-D sera from different sources to mediate the
lysis of Rh(D) positive red cells in ADCC (Section
3.2), and there is no obvious correlation between
anti-D levels (expressed as iu/ml) and ADCC
activity (expressed as % specific lysis). The
cases studied were selected to provide a range of
unusual features which are encountered from time to
time during the management of HDN.
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4.5 The use of ADCC activity in predicting severity of
HON
It is not always possible to predict Rh-HDN by
conventional titration of maternal anti-D levels,
and in any case manual titration methods are
susceptible to large errors. Automated methods for
the quantitation of anti-D have been developed
using continuous-flow quantitation in an
Autoanalyser TM, and this is more accurate and
sensitive than manual titration (Gunson e t a 1 ,
1972). Some workers (Fraser and Tovey, 1972) have
found that continuous-flow quantitation of anti-D
provides a more accurate basis for prediction of
the outcome of HON than do manual methods, although
other workers have not agreed (Sturgeon and Kay,
1970; Cramer et a 1 , 1970). The generally poor
correlation between manual and automated methods
noted by others (eg Fraser and Tovey, 1976) was
confirmed in this study. Although statistically
significant associations were seen between
continuous-flow quantitation and manual titration
methods (enzyme and antiglobulin techniques) the
results in individual cases did not allow accurate
comparisons to be made (Table 14). ADCC activity
of the anti-D sera did not correlate with any of
the conventional methods of assaying anti-D.
Recent studies have shown that Rh(D) positive
babies will be affected by HDN if the anti-D level
is greater than 5 iu/ml (= 1 ^g/ml) (Tovey and
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Haggas, 1971, Fraser and Tovey, 1978). However, in
patient MD (Fig 15 and Table 19) the anti-D level
never reached 2 iu/ml and the baby was affected by
HDN, requiring exchange transfusion. Although the
anti-D level had suggested prediction of a good
outcome the .anti-D ADCC had shown high lytic
activity. On the other hand, the anti D levels in
patients PB and CC were higher than 5 iu/ml at the
end of the pregnancy, but neither baby required
exchange transfusion (just a simple red cell
transfusion for anaemia in the baby of CC). In the
cases of patients AO'N and VMcA (Table 19 and
Figure 16) the anti-D levels prior to amniocentesis
suggested a good outcome, but following
amniocentesis the levels rose markedly. However,
ADCC assays gave reliable predictions throughout.
In the three cases in Series 1, the liquorAOD 450
prediction (favourable outcome), was at variance
with the serum anti-D level prediction (poor
outcome). When these sera were examined "blind"
for ADCC activity, this assay correctly identified
the case where only mild HDN occurred (AM, Fig 17).
In the Series 2 cases where high anti-D levels
indicated a poor outcome, and the amniocentesis
results concurred (IUT zone), the ADCC assays
revealed highly active sera (Fig 18) and three of
these five babies subsequently died of HDN (Table
21). The high ADCC activity of these anti-D sera
therefore reflected the in vivo biological
potential for lysis of Rh(D) positive red cells.
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Two of the cases in Series 2 had favourable
amniocentesis predictions but high anti-D levels,
and again the ADCC assay identified these two sera
as having low potential for Rh(D) positive red cell
lysis (Fig 18). In one case (EK, Fig 18, Table
21), anti-D, amniocentesis and ADCC predictions
were all incorrect in that each predicted an
affected baby, yet a Rh(D) negative infant was
born. In this case the activity of the anti-D
presumably reflects events in a previous pregnancy,
but no details were available to confirm this.
Generally, only single samples of anti-D were
tested in each of these cases (Series 1 and 2), due
to lack of sufficient sera. In previous studies no
case was seen of a non-lytic anti-D which became
lytic, or vice versa during the course of pregnancy
(Table 19, Figures 9, 15 and 16). It is therefore
likely that similar ADCC results would have been
obtained in those cases where the anti-D sample was
taken following amniocentesis (see Tables 20 and
21). Although sera highly active in ADCC can be
correlated with a severely affected baby, the
absolute level of ADCC activity does not
necessarily distinguish between degrees of severity
of HDN. In the in vivo situation the degree of
lysis appears to depend on the ADCC activity of the
foetal effector cells, the Rh(D) antigen density on
the foetal red cells and the level of anti-D in the
foetal circulation. In the test situation the
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effector cells and the Rh(D) positive target cells
were standardized, and the anti-D reflects the
maternal (rather than the foetal) level of
antibody. It is therefore to be expected that the
ADCC assay may give "false positive" results in the
case of a Rh(D) negative foetus, since the anti-D
is being assessed in an artificial context.
Similarly, differences in the activity of foetal
cells to mediate ADCC influence the degree of in
vivo lysis, and the in vitro ADCC assay may
overestimate the severity of HDN if,the effector
cells of the foetus are unable to act efficiently.
Anti-c is the commonest cause of severe HDN, after
anti-D. Affected infants may require exchange
transfusion and perinatal deaths can occur (Table
23). In this study the aim was to test various
anti-c sera for ADCC activity and to correlate any
such activity with the IAGT titre, IgG subclasses
distribution, and the clinical severity of HDN. In
general, the IAGT titre does not correlate well
with severity of HDN. Although two out of six of
the patients tested had the same IAGT titre (ER and
AP, Figure 22), one of these (ER) had an affected
baby which required exchange transfusion, while the
other (AP) had a healthy child, and this had been
identified by low activity in the ADCC assay.
There was a tendency towards higher 1963 titres of
anti-c which were lytic by ADCC.
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The present ADCC test system for assessing anti-D
(or anti-c) activity employs lymphocyte "K-cells"
but in principle there is not a priori reason why
other effector cells (such as monocytes) should not
be used. Provided that the effector cells and
target cells are used under standardised
conditions, the end result will be the same
estimation of the lytic potential of the anti-D
sera. Since the present assay allows addition of
whole sera directly to the culture system it was an
advantage over monocyte ADCC assays, which are
inhibited by the presence of human serum (Shaw et
aj_, 1978 ).
On the basis of the present observations, it would
appear that the ADCC assay has a place in the
identification of those cases of HDN which are
going to have a satisfactory outcome, despite the
level of anti-D as determined by conventional
methods (manual titration in the case of anti-c).
Amniocentesis, with the consequent danger of
boosting antibodies could therefore be avoided.
Although high lytic activity will generally
correlate with a severely affected baby, "false
positive" predictions may occur in the case of
Rh(D) negative babies.
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4.6 Rh immunization in male volunteers
In this study, changes in vitro lymphocyte function
were detected during the course of deliberate
immunization with Rh(D) positive red cells in vivo.
Those individuals who eventuallly produced anti-D
(responders) reacted differently from those who did
not (non-responders ).
Alterations in lymphocyte ADCC activity were seen
following the primary immunization (Figure 23) of
Rh(D) negative male volunteers. In this instance,
a fall in K-cell activity was seen following
infusion. Anti-D was not present at the time of
infusion so that active haemolysis was not
observed. Nevertheless, there was transient
reduction in K-cell activity, followed some time
later by greatly increased K-cell activity. It is
possible that there is a redistribution of K-cells
following infusion (eg) to the spleen.
Changes in K-cell activity were seen in each of two
volunteer studies (R1 and R3) in relation to
primary immunization. However, two of the male
volunteers did not produce anti-D and showed no
changes in K-cell activity (Figure 24). However,
this latter effect may be an artefact introduced by
the method of sampling at a fixed time (7 d)
following primary immunization.
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Following boosting, marked transient depression of
lymphocyte ADCC during immunization was seen only
in the four anti-D responders. This reduction in
ADCC activity was due to abolition of K-cell
function rather than a shift in the dose-response
curve (Fig 26). Although the effect of immuniz¬
ation on ADCC appears consistent, the magnitude of
the response apparently diminishes with successive
immunizations (Fig 27). Examination of ADCC
activity at more closely-spaced time intervals
(Figs 27 - 30 ) showed that depression of ADCC may
occur sooner, but is of similar magnitude, with
later boosts.
It is interesting to note that reduction in ADCC
was seen only in responders, and not non-
responders. The ADCC assay can not distinguish
between loss of function or loss of K-cell numbers,
and it is not possible to determine directly
whether the changes noted are due to inhibitory
influences or to removal of K-cells from the
circulation. Reduction in ADCC occurred when serum
anti-D levels had risen considerably. It is there¬
fore possible that injected R h(D ) positive red
cells become sensitized with anti-D in vivo,
resulting in removal or inactivation of K-cells in
the circulation by interaction with the Fc recep¬
tor: the higher the anti-D level, the more
efficiently the K-cells might be "neutralized".
However, a maximum of 0.5 ml Rh(D) positive red
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cells were injected at each boost and it is
difficult to envisage this as being sufficient to
remove most of the K-cells from the circulation
effectively.
The changes seen could be due to i mmu noregu1 atory
influences on the K-cell, secondary to the
regulation of the immune responses in vivo. It has
been noted recently that in vitro expression of
ADCC may be influenced by suppressor lymphocytes
(Pollack and Emmons, 1979) and there is some
evidence that this effect may be mediated by
soluble factors (Madhavan and Schwartz, 1981).
There are also data available which indicate that
ADCC activity can be influenced by cytokines such
as interferon (Herberman et al , 1 979 ), although no
effect was seen by Kimber and Moore (1981) using an
anti-D ADCC system similar to that used in this
study. A variety of agents that can influence
intrace 11u1 ar levels of cyclic AMP or cyclic GMP
are known to influence expression of Fc receptors
by T cells (Gupta, 1979). Since it has been shown
that the T cell bearing Fc receptors is capable of
effecting ADCC (Shaw et a 1 , 1 979 ; Katz and Fauci,
1980) these agents may alter K-cell activity.
Those responders who developed anti-D showed normal
ADCC lytic potential comparable to that of the con¬
trol anti-D serum (SL) (ie they did not show evi¬
dence of inhibition of the control lymphocyte ADCC
capacity (Figs 31, 32).
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4•7 Secondary Rh immunization in females
Of the six women studied (Tables 26 and 27), three
lost their babies due to intrauterine death, the
others delivered live babies, two of which were
Rh(D) negative (and therefore not responsible for
the anti-D changes noted during plasma exchange)
and one which required exchange transfusion and
survived. Interpretation of the laboratory
findings associated with pregnancy is more complex
than with immunized male volunteers because: i)
the immunizing event can not be clearly documented;
ii) the possible effects of plasma exchange on
homeostatic immunoregulati on can not be predicted;
and iii) the status of the immune system in
pregnancy may differ from that in non-pregnant
subjects. HDN differs from other antibody-mediated
diseases in that the foetus can benefit only
indirectly from plasma exchange, effects depending
upon the free passage of antibody between foetus
and mother. I g G levels in the newborn are
frequently higher than in the maternal serum
(Koh 1 e r et a 1 , 1966 ) and the level of anti-D may
vary from 2% to 30% of that found in the mother
(Hughes-J ones et a 1 , 1971). Maternal anti-D
concentrations therefore can not provide an
accurate prediction but only a guide to the
severity of the disease. Initially it appeared
that the maternal anti-D levels increased despite
intensive plasma exchange, and that the procedure
may have been harmful by removing maternal
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"inhibitory" activity (Barclay et a 1 , 1980).
Whether plasma exchange alone provoked the anti-D
response in patient AB, or whether further
sensitization to foetal cells occurred at a vulner¬
able time in relation to the removal of the
inhibition is not clear. Rh(D) positive foetal
cells were not detected in the maternal circulation
by the Kleihauer technique at the time of
amniocentesis or of IUT at day 1, which would be
likely in the event of immunization (Zipursky et
a 1 , 1963 ). However, failure to detect foetal cells
in the maternal circulation does not exclude the
possibility of foeto-maternal haemorrhage, as such
cells are rapidly cleared in the presence of potent
anti-D (Jandl et a 1 , 1957). A more important
additional factor may have been the presence of
Rh(D) positive cell stroma in the FFP, since this
was randomly selected as regards Rh group and was
used in five of the six cases. It has been shown
that red cells present in carefully prepared packs
of plasma prior to freezing may average the
equivalent of 0.06 ml blood per pack (range
0.005-0.25 ml), and that when a pack is frozen and
thawed, 4% of the erythrocytes may survive intact
(Wensley et a 1 , 1980). Similarly, McBride (1983)
demonstrated that an average bag of 220 ml plasma
may contain approximately 10^ red cells; this is
approximately equivalent to 2.5 ml of whole blood,
or 1.0 ml of packed cells. If 20 bags of FFP are
used for a 4 1 plasma exchange, as much as 0.05 ml
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in intact R h(D) positive red cells might be
transfused - an amount capable of stimulating an
antibody response (Jakobowicz et al, 1972).
However, the placenta does not act as a simple
filter, but bears Fc receptors and appears to be
the rate-limiting point in antibody transfer
(McNabb et al , 1976). It selectively and
directionally transfers I g G against a substantial
concentation gradient. The rate of transfer is
relatively slow (Giltin et a 1 , 1964) but is better
from mother to foetus than from foetus to mother.
Because of the active and selective transfer of IgG
across the placenta it was elected to exchange with
FFP rather than with PPS, in an effort to maintain
total I g G levels while reducing the Ig G anti-D
component. However, long term transfusion of large
amounts of FFP is associated with unacceptable side
effects (Robinson, 1983; Urbaniak 1984) and one is
obliged to use PPS during intensive plasma exchange
(Table 27).
It has been shown in animal experiments by Branda
et a 1 (1975) that plasma exchange following
secondary immunization results in a permanent
lowering of the antibody level. However, it has
recently been stated (Branda, 1979) that when
antigen is continuously present only a temporary
lowering of antibody can be achieved, with a prompt
return to high levels.
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Certain patterns emerged from the present studies
which become evident if one divides the patients
into three groups, .according to the outcome of
their pregnancy (Table 27):
i) those in whom intrauterine foetal death
<
occu rred;
ii) those who delivered an Rh-negative child;
iii) those who delivered a live R h(D) positive
child.
The changes in variables in groups i) and ii) can
be contrasted with group iii), and with the changes
which occurred in the same variables measured in
male volunteers.
Dramatic rises in anti-D production rates occurred
during plasma exchange therapy in 5 cases. In
group i) these were not brought under control by
plasma exchange therapy, but in group ii) they were
brought down after apparent reductions in the rate
of anti-D production in vivo. In the group ii)
cases, stimulation of anti-D production could have
been brought about by exposure to the exchange
(donor) plasma, and selected plasma from Rh(D)
negative donors was subsequently used for all
exchanges, to exclude any possibility of exposure
to Rh(D) positive red cell stroma which might
otherwise occur. However, in the group iii) case,
no plasma from any Rh(D) positive donor was used
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and the anti-D concentration was kept low, in the
range of 5 iu/ml, until the end of the plasma
exchange therapy. In three cases, the removal of
anti-D by plasma exchange was accompanied by an
increase in anti-D ADCC lytic potential, despite
the net reduction of anti-D content (Figs 33, 34,
36). This may have been due to the joint removal
of some lymphocyte K-cell (ADCC capacity) inhibit¬
ing factor from the sera, together with the anti-D.
In turn, this could imply that observed serum anti-
D ADCC lytic potentials depend on both serum anti-D
and regulatory factors directed against K-cells in
a given serum. However, in groups i and ii when
the anti-D concentrations reached their highest
level due to secondary anamnestic responses, un¬
expectedly, the anti-D lytic potential was markedly
decreased. This may be due to the different route
of immunization used (ie intravenous rather than
transplacental) which may have peturbed the homeo-
static regulation of the anti-D response which may
indicate that the placenta plays a unique role in
the immunization process. In group iii (HA), where
there was no extrinsic antigenic stimulus, the
anti-D lytic potential was consistently high. In
general, no correlation was found between anti-D
levels and anti-D ADCC lytic activity.
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Only in the group ii) andiii) cases were intrinsic
lymphocyte ADCC activities studied as for the
immunized male volunteers. Two patients showed a
dramatic short-lived- drop in intrinsic lymphocyte
ADCC capacity in the early stages of exchange
therapy, which resembled that seen in the
successfully immunized male volunteers following
boosting. However, in one case (HA) no significant
changes in intrinsic lymphocyte ADCC capacity
occurred, which resembled the situation in
non-responders amongst the male volunteers. The
data in the first five cases (Table 26) could
represent facets of a well-co-ordinated immune
response rather than initiating factors of that
response. The data are alike and confirm the
findings made in secondary immunization (boosting)
in male volunteers.
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4.8 Conclusion and prospective studies
This work raises several important points calling
for further research. The lytic, capacity of
various anti-D sera in ADCC has been investigated
and unexpected differences were found between the
ADCC of anti-D produced in male volunteers and that
from pregnant females. Although the males produced
high levels of anti-D, as measured in iu/ml, the
ADCC activity induced was much less than that of
the "female" anti-D at equivalent concentrations.
Certain anti-D sera failed to induce lysis of Rh(D)
positive red cells by ADCC, although they were
capable of binding D-antigen, as measured by
conventional haemagglutination techniques and by
IRMA and Fc receptor binding studies. The IgG
subclass distribution between different sera could
not account for the differences seen, either IgG^
or IgGg, and/or both, were present in all sera.
As fewer women become immunized as a result of
pregnancy, there is greater dependence on anti-D
from male volunteers, for the production of
specific immunoglobulin for therapeutic use. The
demonstration that anti-D from male donors is not
as potent as that from females in ADCC raises the
intruiging possibility that anti-D from males may
be less effective in the prophylaxis of Rh HDN.
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Possible areas for further studies to distinguish
between lytic and non-lytic anti-D are:
i) by study of the biochemistry of the
components ;
ii) chromatography, eg multi-step or gradient
elution with phosphate solution and use of
alternate eluants ;
5 1
iii) in vivo study of the survival of Cr-labelled
Rh(D) positive red cells after injection of
lytic and non-lytic anti-D, using different
groups of volunteers, etc. However, the
hazards of taking part in such a study must be
fully explained to the volunteers;
iv) a search for a better reagent to determine the
IgG subclasses (_e£ monoclonal antibodies).
When ADCC assays were used for predictions of the
severity of HDN there was a problem with "false
positive" reactions when Rh-negative infants were
involved. It may be possible to overcome this by
using the father's red cells as targets with
maternal anti-D.
Lymphocytes are the source of both humoral
(antibody) immune response and regulatory
activities which govern the expression of specific
immune responses, and therefore studies of
lymphocyte functions in vitro will give an insight
into the mechanisms which operate in vivo. 11
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would be important to study the lymphocyte
intrinsic ADCC activity in male volunteers
following primary immunization, in parallel with
differential studies of lymphocyte subpopulations.
It is possible that changes seen in lymphocyte ADCC
activity in relation to boosting could be secondary
to alteration in T-cell activity. It has been
noted that the T-cell, with I g G receptors (Tq
suspopulation) is active in the anti-D system (M
McCann, 1984, personal communication).
Immunoregulati on is seen as a homeostatic process.
During an immune reasponse active regulatory
mechanisms, termed "helper" and "suppressor" (T )
determine the nature of the response, expressed by
their balance, with restoration of homeostasis and
de-activation of regulation after antigen
elimination .
It has been shown that the intrinsic responsiveness
of peripheral blood lymphocytes is depressed
f o11owin g in vivo immunization, and this has been
attributed to activation of suppressor cells (T ).
Ts can also be activated in vitro by exposing
normal PBL to antigen or mitogen (Barclay et al,
1979; Barclay, 1980). This may indicate that
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